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ABSTRACT
Rhodopsin is an integral membrane glycoprotein that is the G protein-
coupled receptor of the rod cell. 11-cis Retinal, a vitamin A analog,
binds to the apoprotein, opsin, via a protonated Schiff base linkage
with lysine 296. Bovine rhodopsin has three major covalent
modifications: 1) A single disulfide bond between cysl10 and cys187;
2) Two palmitoylated cysteine residues at 322 and 323; 3) Two
asparagine(N)-linked glycosylation sites at asn2 and asnl5.
Previously in our laboratory opsin has been expressed in COS-1 cells,
regenerated with 11l-cis retinal and immunoaffinity purified. The
yield of opsin from these cells was about 10 gig/1.25-1.5 X 107 cells.
In an attempt to obtain greater quantities of protein, bovine opsin was
expressed in the baculovirus/insect cell system. A method was
developed to obtain pure rhodopsin. Furthermore insect cell
rhodopsin had N-linked glycosylation similar to rod cell rhodopsin,
was palmitoylated and triggered transducin like it as well. The total
amount of opsin produced by insect cells was about ten-fold greater
than COS-1 cells. However the amount of purified rhodopsin was 1/10
on a cell-per-cell basis. A large fraction of insect cell opsin did not
regenerate and was misfolded. Despite this, expression of rhodopsin
mutants in insect cells may be an attractive alternative expression
system since they can be grown at high density in suspension.
Our laboratory has established the role of the single disulfide bond
and of palmitoylation by site-directed mutagenesis and biochemical
studies. Using a similar approach the role of glycosylation in
rhodopsin folding, transport and function has been studied.
Complementing this approach wild-type opsin has been expressed in
the presence of tunicamycin (TM), a well-known inhibitor of N-linked
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glycosylation. Glycosylation does not affect the folding or transport of
opsin. However unglycosylated opsin is 1/10 less efficient in
triggering transducin, the cognate G-protein of the rod cell.
Retinitis Pigmentosa (RP) is a hereditary retinal degeneration. It is the
most common cause of blindness in people under the age of 50. Its
prevalence is 1/3000 live births. RP can be inherited as an autosomal
dominant, autosomal recessive or X-linked trait. The clinical
hallmarks of this disease include nightblindness, mid-peripheral visual
field loss, progressive diminution of electroretinogram (ERG) signals
and eventual blindness, most often before the age of 60.
Within the past four years over 40 mutations in the opsin gene have
been described to be associated with autosomal dominant retinitis
pigmentosa (ADRP). Most of these mutants are single amino acid
substitutions, a few are small deletions. Some amino acid positions
have multiple substitutions. Nearly all of the currently known
mutations have been constructed by site-specific cassette mutagenesis
of the bovine rhodopsin gene. After confirming the presence of the
mutation by DNA sequencing, the mutant genes have been expressed
in COS-1 cells, immunoaffinity purified and studied biochemically.
There is significant heterogeneity among the mutant proteins. They
can be classified into three groups: Class I (e.g. L125R) had wild-type
levels of expression and chromophore formation. These mutants also
had wild-type glycosylation and were transported to the cell surface.
Class II mutants (e.g. P171L) were expressed at 1/2 to 1/3 of wild-
type, did not form any chromophore and had abnormal glycosylation.
They were retained in the endoplasmic reticulum (ER). They
represented misfolded forms of opsin. Class III (e.g. P23H) mutants
were expressed at levels similar to the Class II mutants but they
formed come chromophore but the amount was less than 1/2 to 1/3 of
wild-type. These mutant proteins were also abnormally glycosylated
and retained in the ER. They probably represent slow folding forms of
opsin. The majority of the ADRP mutant proteins fell into the class II
and class III categories. The photobleaching behavior of all the
mutants that formed chromophore was also studied as well as their
ability to trigger transducin. Nearly all the mutants bleached more
quicklu upon illumination i.e. they released the phtoisomerized
chromophore, all-trans retinal, more rapidly than wild-type rhodopsin.
These mutants also triggered transducin less efficiently than wild-
type. This finding provide a biochemical basis of nightblindness in
these patients.
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Chapter 1
INTRODUCTION
1.1 The Eye and Retina
The human eye is the sensory modality that mediates light
perception. As such it is has specific receptors for detecting low light
intensities as well as color. The eye is composed of many transparent
tissues including the lens, aqueous humor and the vitreous humor
whose primary purpose is to filter and focus the incoming light
stimulus to the retina (Figure 1-1) (Schichi, 1983).
The retina is composed of both non-neural and neural
components. Immediately anterior to it is the vitreous humor.
Posterior to the retina is the retinal pigment epithelium (RPE) followed
by the choroid and sclera. These tissues provide the metabolic and
nutritional requirements of the neural retina. The RPE does not
directly contact the neural retinal cells but plays a critical role in the
phagocytosis and subsequent turnover of both photoreceptor cell
types, the rods and the cones.
Structurally the retina is organized in various layers (Schichi,
1983). Beginning from the vitreous side the six layers include the
inner limiting membrane, the nerve fiber layer, the inner plexiform
15
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Figure 1-1 Anatomy of the eye.
transparent vitreous humor.
The neural retina is located next to the
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layer, the outer plexiform layer- it contains the photoreceptor cells
predominantly, the outer limiting membrane and Bruch's membrane
(Figure 1-2). Light traverses nearly the entire neural retina before it
strikes the photoreceptor cells. Interestingly the photoreceptor cells
face the posterior aspect of the eye so that light must travel nearly the
entire length of the rod or cone before it interacts with the
appropriate receptor. In many ways the structural architecture of the
eye is similar to that of a camera. The iris is a shutter that controls
the amount of light which is received by the lens. The lens itself
focuses the light stimulus onto the retina. It along with the aqueous
humor, vitreous humor and the RPE serve to filter ultraviolet light as
well as absorb reflected light within the eye, thereby preventing
internal glare. The retina, of course, serves as the photographic film.
1.2 The Photoreceptor Cells: Rods and Cones
As mentioned previously the cells which mediate the primary
events in visual transduction are the rods and cones. The cones are
pyramidal shaped cells which allow for the perception of color. They
are found in the central retina and are the major photoreceptor type
found in the macula- the region of highest visual acuity. In humans,
there are three distinct populations of cones- one subtype absorbs
light primarily in the 445 nm region whereas the other two detect
light in the 535 and 570 nm region respectively. These correspond to
the absorption maxima of the three known human color pigments.
Cones are 1-1.5 m in thickness and are about 75 m in length. The
average eye contains about 6.5 X 106 cones. Morphologically they
17
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Figure 1-2 Anatomy of the sensory retina. The rods and cones are
located furthest from the vitreous so that light must transverse the entire
length of the retina before being absorbed by the visual proteins.
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consist of an inner segment and an outer segment. The outer segment
is where the color pigment receptors are found in a series of
invaginated membrane structures called disks that are contiguous
with the plasma membrane of the inner segment.
Rod cells are approximately 1-3 1tm in thickness and 40-60 pm
in length. They are found predominantly at the periphery of the
retina in contrast to the cones. Their primary purpose is to mediate
vision in dim light. There are appoximately 120 X 106 rod cells in the
eye. They absorb light maximally at 500 nm- the absorption
maximum of rhodopsin, the visual receptor of these cells.
1.3 The Rod Inner and Outer Segments
The rod cell, like its cone counterpart, consists of an inner
segment as well as an outer segment (Figure 1-3). They are referred
to as the rod inner segment (RIS) and the rod outer segment (ROS).
The inner segment is where rhodopsin is synthesized and inserted into
the membrane of the endoplasmic reticulum (ER). While in the ER
compartment opsin is covalently modified by being glycosylated
(Young, 1976, O'Brien, 1978; Papermaster and Schneider, 1982),
disulfide bonded (Gething and Sambrook, 1992) and palmitoylated
(Pfanneret al., 1989). 1-cis Retinal binds to the properly folded,
mature opsin before it exits from the ER (St. Jules et al., 1989).
Subsequently rhodopsin is shuttled to the Golgi apparatus via
membrane transport vesicles where the carbohydrate moieties are
trimmed back and further modified by the addition of other sugars
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(e.g. galactose) (Smith et al., 1991). Finally rhodopsin is transported
from the inner segment through a narrow structure called the cilium
to the outer segment (Papermaster et al., 1985; Deretic and
Papermaster, 1991).
In the outer segment rhodopsin is found either within the
plasma membrane or invaginated disks (Molday and Molday, 1987).
Unlike the cone disks, the rod disks are not contiguous with the
plasma membrane (Figure 1-3). Because of the topology of membrane
fusion and budding the N-terminus of rhodopsin faces into the disk
membrane's lumen whereas the C-terminus faces the cytoplasm of the
outer segment where all the accessory proteins of visual transduction
reside (Hargrave and Fong, 1977; Adams et al., 1978; Clark and
Molday, 1979; Dratz et al., 1979).
1.4 Rhodopsin- The Photoreceptor Protein
1.4.1 Rhodopsin Structure
Bovine rhodopsin is an integral membrane protein of 348 amino
acids ( Ovchinnikov et al., 1982; Hargrave et al., 1983; Nathans and
Hogness, 1983). A secondary structure model is shown in Figure 1-4.
It has seven transmembrane segments, as determined by hydropathy
analysis, resulting in the N and C terminus being on opposite sides of
the lipid bilayer (Ovchinnikov et al., 1882, Hargrave et al., 1983).
From circular dichroism (CD) measurements the helical content of
rhodopsin is about 60%, as determined in the disk membrane or in
20
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Figure 1-3 A) Scanning micrograph of rod cells; B) Schematic diagram
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detergent micelles (Schichi et al., 1969; Albert and Litman, 1978).
There is a conformational change in rhodopsin after photoexcitation
resulting in the loss of some helical content and the exposure of
additional cysteine residues to the alkylating agent N-ethylmaleimide
(NEM) (deGrip et al., 1973). Recently, a low resolution projection
structure of about 7 A has been determined for rhodopsin (Schertler
et al., 1993). It confirms there are indeed seven transmembrane
segments.
1.4.2 The G Protein-Coupled Receptor Superfamily
Rhodopsin belongs to a superfamily of G protein receptors which
have seven transmembrane segments. The list of these receptors is
ever-growing (Table 1-1) (Iismaa and Shine, 1992). The best studied
members of this family include rhodopsin and the a and 3-adrenergic
receptors. Rhodopsin has been extensively studied since it can be
purified in large quantities from the rod outer segment. It constitutes
about 70% of the total protein of the outer segment and nearly 90% of
the disk membrane (Hargrave and McDowell, 1992).
1.4.3 Spectral Properties of Rhodopsin
The chromophore, 11-cis retinal, is attached by a protonated
Schiff base linkage to lysine 296 in helix G (Bownds, 1967). Once this
occurs rhodopsin acquires a distinct UV/visible spectrum in which
there are three distinct peaks at 280 nm, 340 nm and 500 nm (Figure
1-5). The 280 nm peak represents the collective contribution of all
23
Table 1. Cloned G protein-coupled receptors categorized according
to endogenous Igand
Peptidespeptide hormones
Angtotpnsin II
Bombesin/gastrnn-releasing peptide
Bombesin,'neuromedin B
Bradykinln
CSa anaphylatoxin
Calcitonln
Endothelin (2)
Follicle-stimulating hormone
N-formyl peptide (2)
Interleukin-8 (2)
Luteinizing hormone/chorionic gonadotropin
Neurokinin A (substance K)
Neuroklnin B (neuromedin K)
Neuropeptide Y/peptide YY (3)
Neurotensin
Parathyroid hormone/parathyroid hormone-related peptide
Secretin
Somatostatin (2)
Substance P
Thyroid-stimulating hormone (Thyrotropin)
Thyrotropin-releasing hormone
Vasoactive intestinal polypeptide
Neurotransmitters
Adenosine (2)
Adrenergic (12)
Dopamine (6)
Glutamate (3)
Histamine (2)
Muscannic acetylcholine (5)
Octopamine
Serotonln (5)
Tyramine
Other regulatory factors
Cannabinoids
Cyclic AMP
Cytomegalovirus proteins (3)
Platelet-activating factor
Prostanoid thromboxane A2
Thrombin
Yeast mating factors (2)
Sensory stimuli
Light (4)
Odorants (> 100)
Orphan receptors (> 6)
Numbers in brackets refer to the number of molecular subtypes
cloned to date.
Table 1-1 Members of the seven transmembrane segment G-protein
coupled receptors.
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Figure 1-5 UV / visible absorption spectra of rhodopsin, porphyropsin,
and iodopsin. All three pigments have a and bands due to the
retinylidene chromophore and y band due to the opsin protein.
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0.6
the tyrosine and tryptophan residues in the protein. The other two,
of which the 500 nm peak is the largest and most distinctive for
rhodopsin, represent the interaction between the amino acid residues
that form the binding pocket for retinal. Model studies have
demonstrated a protonated Schiff base in solution has an absorption
maximum at 440 nm (Figure 1-6) (Blatz et al., 1972). Denaturation of
rhodopsin with either acid or sodium dodecyl sulfate (SDS) results in
such a species (Kito et al., 1968), suggesting the 60 nm red shift must
be due to specific interactions between the residues of the retinal
binding pocket and the chromophore.
1.4.4 Covalent Modifications
Rhodopsin has three known covalent modifications. First, a
single disulfide bond exists between cysl0 and cys187 . The
presence and importance of this linkage for the folding and stability of
opsin has been established by both biochemical and mutagenesis
studies (Karnik et al., 1988; Karnik and Khorana, 1990). Second,
rhodopsin is palmitoylated at cys322 and cys323 (Ovchinnokov et al.,
1988, Papac et al., 1992). From previous mutagenesis studies the
replacement of these cysteine residues with serines has little
consequence on the folding and function of rhodopsin, despite the lack
of palmitoyl groups (Karnik et al., 1993). Third, bovine rhodopsin has
two asparagine (N) -linked glycosylation sites at asn2 and asn15
(Fukuda et al., 1979; Schichi et al., 1980). There is another site at
asn200 but from peptide analysis that position does not have any
attached carbohydrate moieties (Fukuda et al., 1979). The
26
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Figure 1-6 UV / visible absorption spectra of a model Schiff base, N-
retinylidene-n-butylammonium chloride, bromide, iodide and picarate in
CC14.
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mutagenesis and biochemical studies on the role of glycosylation are
presented as part of this thesis. There is a fourth covalent
modification of rhodopsin, phosphorylation, that occurs after
photoexcitation. It is part of the mechanism by which the receptor is
inactivated (Kuhn et al., 1984).
1.4.5 The Three Regions of Rhodopsin
From prior biochemical and mutagenesis studies much has been
learned about the structure and function rhodopsin. The intradiscal
region is important for correct folding and assembly (Doi et al.,1990).
It is on this face of the molecule the single disulfide bond is found. For
example, deletion mutants at the N-terminus or in the conserved
portion of the DE loop regenerate poorly or do not regenerate at all i.e
they do not form the characteristic 500 nm absorbing species in the
presence of 11-cis retinal. These mutants are retained in the ER of
COS-1 cells, consistent with them being misfolded. They also do not
acquire the distinctive glycosylation smear found with wild type
rhodopsin. It is unknown if these intradiscal mutants form the
disulfide bond.
The transmembrane region contains within it the retinal binding
pocket, lys296 and the counterion to the protonated Schiff base,
glul 13. Lys296 is not necessary for the formation of the 500 nm
chromophore. In a series of elegant experiments Zhukovsky and
Oprian (1992) demonstrated when this residue is mutated to glycine it
can bind a propylamine derivative of 11-cis retinal and form a 500
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nm chromophore which upon photoactivation can trigger transducin.
The behavior of this mutant is similar to other G-protein coupled
receptors that bind ligands non-covalently.
From cross-linking experiments with a photoactivatable analog
of retinal and mutagenesis studies Nakayama and Khorana (1990,
1991) established some of the residues forming the retinal binding
pocket. These include phell15, alall17, glu122, trpl26 and serl27 in
helix C along with trp265 and pro267 in helix F. Interestingly the
mutants E122Q and W265F had blue-shifted absorption maxima at
480 nm.
The role of glul 13 as the Schiff base counterion has also been
established by mutagenesis (Sakmar et al., 1989; Zhukovsky and
Oprian, 1989; Nathans, 1990). When this residue is changed to gln the
mutant rhodopsin has a max= 380 nm. This species exists in a pH-
dependent equilibrium with a 500 nm chromophore. This mutant can
also bind to all-trans retinal in the dark and trigger transducin in the
absence of light.
The cytoplasmic loops are critical for the interaction of
photoactivated rhodopsin with transducin (Konig et al., 1989; Franke
et al., 1990; Franke et al., 1992). From both mutagenesis and peptide
competition studies loops CD, EF and the one extending from helix G to
the palmitoylated cysteines 322, 323 are important for transducin
binding and activation. It appears there is a synergistic effect
between these loops.
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1.4.6 Light Activation of Rhodopsin
The primary event of visual tranduction is the isomerization of
11-cis retinal to all-trans retinal (Figure 1-7). This photochemical
conversion occurs in approximately 2-5 nanoseconds (Schoenlein et al.,
1991). The activation energy for this reaction is nearly 50 kcal/mole
(Cooper, 1979). Immediately upon isomerization there is no
detectable conformational change in the protein itself. The
photoexcited species then decays , within a millisecond, through a
series of photointermediates to metarhodopsin I (mI) (Figure 1-8).
These intermediates can be trapped and studied at low temperatures.
Metarhodopsin I exists in a pH and temperature-dependent
equilibrium with metarhodopsin II (mII)- the species that interacts
with transducin (Kibelbek et al., 1991). It also is the substrate for
phosphorylation and subsequent inactivation. Certain detergents like
digitonin favor the formation of m whereas others like dodecyl
maltoside (DM) favor mIIl. All-trans retinal is covalently bound to the
protein in metarhodopsin II (Cooper et al., 1987). In vitro it can decay
to either free all-trans retinal and opsin or metarhodopsin III (mIII).
This intermediate absorbs at 465 nm and can also decay to all-trans
retinal and opsin. In vivo the free all-trans retinal is shuttled via a
carrier protein to the the RPE cells where it is reisomerized to 11-cis
retinal (Rando, 1991). This is then transported back to the rod cell
inner segment, where it can combine with newly synthesized opsin.
1.5 The Visual Cascade
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Figure 1-7 The chemical structure of 1 l-cis retinal and its
photoconversion to the all-trans form.
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Figure 1-8 The photobleaching sequence of rhodopsin.
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As mentioned mII is the photointermediate which triggers
multiple transducin molecules, the rod cell G-protein, also abbreviated
as GT. The activated GT's then turn on many cGMP phosphodiesterase
(PDE) molecules resulting in a decreased concentration of cGMP. This
in turn leads to the closing of cGMP-gated channels and rod cell
hyperpolarization (Figure 1-9) (Fung et al., 1981; Chabre and Deterre,
1989). Finally an electrical signal is generated in the retina which is
transmitted via the optic nerve to the visual cortex where visual
information is integrated and recorded.
Visual transduction is an exquisitely sensitive sytem resulting in
tremendous signal amplification. There are two distinct stages of
amplification. First, each activated rhodopsin molecule i.e. mIIl is able
to bind and trigger about 500 molecules of transducin, resulting in a
500-fold increase in signal (Liebman and Pugh, 1980; Fung et al.,
1981,). Second, each molecule of PDE can hydrolyze over 1000 cGMP
molecules (Yee and Liebman, 1978). So from a single photoexcited
rhodopsin molecule over 5 X 105 molecules of cGMP can be
hydrolyzed.
1.6 Transducin- The G Protein of the Rod Cell
Transducin is a peripheral membrane protein which is found on
the cytoplasmic side of discs (Fung et al., 1981; Kuhn, 1981). It can be
stripped from the membrane by urea washing. Like other
heterotrimeric G proteins it is composed of three subunits, a (39 KDa),
3 (36 KDa) and y (8 KDa) (Kuhn, 1981). The a subunit is myristoylated
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at the N-terminus and has GDP bound to it in the dark (Stryer, 1983).
When the cytoplasmic loops of mII bind to it, there is an exchange of
GTP for GDP and the dissociation of Gtc from G[y. The mII molecule is
then able to interact with other transducin molecules (Stryer, 1983).
The binding sites for mII on Gac are unknown at this time.
1.7 Phosphodiesterase
The rod cell cGMP phosphodisterase is also a peripheral
membrane protein. It consists of an a (88 KDa), (84 KDa) and y (11
KDa) subunit (Baehr et al., 1979). G-GTP can activate PDE as can
limited tryptic digestion. Activation is associated with the dissociation
of two y subunits from PDE in the former and the proteolysis of the 
subunits in the latter(Miki et al., 1975; Fung et al., 1981; Hurley and
Stryer, 1982). PDE can hydrolyze about 2 X 103 moles cGMP per
second per mole of enzyme (Baehr et al., 1979).
1.8 The cGMP-Gated Channel
cGMP is the second messenger which regulates the cation
channels of the rod outer segment. When there is a decrease in the
cytoplasmic levels of cGMP the cGMP-gated channel is closed leading
to the hyperpolarization of the rod cell. This eventually is transmitted
to the synaptic region where there is neurotransmitter release.
The channel has been purified from the rod cell. It is an integral
membrane protein of 66 KDa (Kaupp et al., 1988). As expected the
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purified molecule, when reconstitued in vitro with lipids, has the same
properties as that found in vivo.
1.9 Inactivation of the Visual System
How does the visual machinery turn off the light response? At
the level of transducin there is an intrinsic rate of hydrolysis of GTP
when it is associated with Ga . However this activity is probably too
slow to have a significant effect (Vuong and Chabre, 1990). At the
level of rhodopsin there are two distinct inactivation mechanisms.
First, in membranes mlI has a relatively short half-life, on the order
of minutes, such that it decays to free all-trans retinal and opsin
(Matthewset al., 1963). Again this is a relatively slow process. Second
and more significantly, it has been demonstrated by many workers
that ml can be phosphorylated by a specific rhodopsin kinase at the
nine serine and threonine residues found at the carboxy terminus of
rhodopsin ( Bownds et al., 1972; Kuhn and Dryer, 1972; Frank et al.,
1973; Kuhn et al., 1973). The phosphorylated species is the substrate
for the binding of arrestin, a 48 KDa protein also known as retinal S-
antigen (Kuhn, 1981; Pfister et al., 1984). When this occurs there is a
great reduction in the amount of mII available for transducin binding.
This mechanism is currently believed to be the method to control
visual inactivation.
1.10 Goals of Thesis
36
The goals of this thesis are threefold. First, opsin was expressed,
purified and characterized in the baculovirus/insect cell expression
sytem. Second, the role of asparigine (N)- linked glycosylation was
explored by mutagenesis and by expressing opsin in the presence of a
well-known inhibitor of N-linked glycosylation, tunicamycin (TM).
Third, the structure and function of the opsin mutants associated with
autosomal dominant retinitis pigmentosa (ADRP) was determined.
In order to study both biochemically and biophysically
rhodopsin and its mutants it is desirable to have an expression system
in which large quantities of the protein are being synthesized and it
can be easily purified. Rhodopsin has been expressed and purified in
our laboratory from COS-1 cells- a monkey kidney cell in which
multiple copies of the SV40 large T antigen have been stably
integrated into the genome. Expression depends on the introduciton of
a plasmid, by transfection, into the cell. The vector, such as pMT4, is a
shuttle vector. It can be easily propagated in E.Coli thereby making it
easy to isolate large quantities of it for transfection. As such it has a
bacterial origin of replication and a -lactamase gene rendering the
bacteria which has this plasmid resistant to ampicillin. Furthermore
this vector has the SV40 origin of replication so that it can replicate to
a large copy number in the presence of large T antigen. In COS-1 cells
we are able to isolate approximately 10 g of opsin from 1.25 X 107
cells. Although many studies can be done with this amount of protein
it is a relatively little when compared to a soluble protein of the same
size. It may be for an integral membrane protein the amount of
folded protein that can be obtained is determined by the available
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membrane. If opsin was expressed in a cell which was larger than
the COS-1 cell greater expression levels could possibly be acheived.
Insect cells are not larger than COS-1 cells. They, however, are
an attractive alternative expression system. Insect cells do not
require any C02 for their survival and grow best at 27°C. This is
particularly advantageous for a biotechnology firm since the costs of
growing surface adherent mammalian cells like COS-1 are prohibitive.
But the real benefit of insect cells is they can be grown at high density
in suspension. Many biotechnology companies have exploited this
property and have grown insect cells in large bioreactors for the
isolation of medically useful proteins.
To express a foreign protein in insect cells the gene of interest
must be incorporated into the baculovirus genome and the
recombinant viral particle must be plaque purified. Opsin expression
in insect cells was driven from the polyhedrin promoter of
baculovirus. As is the case of any viral infection nearly all of the
target cells are infected. This is particularly desirable when
heterologous proteins are being expressed. The polyhedrin promoter is
an extremely powerful promoter which is turned on 24-30 hours post-
infection. Indeed opsin was first observed by immunoblots 24 hours
after infection. A full time course of expression was then done. It was
determined the maximal amount of folded opsin, i.e. that fraction of
opsin which can bind to 11-cis retinal, was found at approximately 72
hours after infection. After that the insect cells began to die and the
opsin was proteolyzed. Since rhodopsin is an integral membrane
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protein, it must be solubilized in some detergent so that it can be
isolated. Other workers have used many different detergents in the
purification of rhodopsin. The stability and spectral kinetics can be
dramatically affected by the choice of detergent. In the past, harsh
cationic detergents have been used. More recently, especially in our
laboratory, the mild alkyl glycosidic detergent, dodecyl maltoside (DM)
also known as lauryl maltoside (LM) has been used. When wild-type
rhodopsin is purified in it the spectral kinetics are similar to those of
rhodopsin in membranes. However it is not known how well LM can
extract opsin from COS-1 or other cells. For insect cells a variety of
detergents were used to solubilize opsin in order to determine which
would extract the greatest amount. Although
dodecyltrimethylammonium bromide (DTAB) extracted the greatest
amount of opsin, little folded opsin could be purified, suggesting this
harsh detergent denatured rhodopsin. DM solubilized less opsin from
whole cells but a 500 nm chromophore could be isolated. However
the rhodopsin isolated was neither spectrally pure, A 2 8 0 /A 50 0 > 1.6,
nor was it pure when analyzed by silver stained gels. A crude plasma
membrane fractionation was developed whereby spectrally and gel
pure rhodopsin was obtained. This rhodopsin had similar transducin
activation as ROS rhodopsin. It also was glycosylated and
palmitoylated.
As mentioned in the introduction the role of rhodopsin's
carbohydrate moieties are unknown. To understand their function
mutations were made at asn2 and asnl5. Other mutations in the
tripeptide consensus sequence required for N-linked glycosylation
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were also made. The mutants were then analyzed for the presence of
glycosylation, their spectral properties including their bleaching
kinetics, their ability to trigger transducin as well as their cellular
localization as determined by immunofluorescence microscopy.
Collectively, these studies clearly suggest that glycosylation at asn2
has little effect on the folding and function of rhodopsin. However
mutations at asnl5 effect the amount of folded obtained. Furthermore
these mutants are located in a perinuclear distribution consistent with
an ER staining pattern. These mutants also bleach more quickly than
wild type and are less efficient in triggering transducin; nearly
1/100th the levels of wild type. It may be glycosylation at asnl5 is
important for the structure and function of rhodopsin but it is equally
possibile that asnl5 besides being a glycosylation site plays an
important structural role.
To deconvolute these two possibilities wild type opsin was
expressed in the presence of tunicamycin. Wt(TM) was not
glycosylated but was palmitoylated and transported to the cell surface.
It has the same spectral properties as the wild type including the mIl
half-life. But this molecule is 1/10th less efficient in triggering
transducin as wild type suggesting that glycosylation has an effect on
the photoactivated form but not the ground state. Furthermore it
appears that asnl5 does in fact have a structural role.
Finally the third part of this thesis explores the structure and
function of nearly 40 of the opsin mutants associated with autosomal
dominant retinitis pigmentosa (ADRP). These mutations had
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heterogeneous effects on folding, bleaching kinetics and the triggering
of transducin. However there are some interesting findings with these
mutants. First, most of the mutant ADRP proteins, including those in
the intradiscal and transmembrane region, are expressed at lower
levels than wild type. They also regenerate more poorly (e.g. P23H,
Class III) or not at all (e.g. P171L, Class II). Second, these same
mutants have abnormal glycosylation and appear to be retained
within the ER- indicative of proteins that are either misfolded or fold
slowly. Third, of the mutants that do form chromophore nearly all
bleach more quickly than wild-type rhodopsin. Consequently, these
mutants are less efficient in triggering transducin.
There are a group of mutants which are similar to wild-type
both structurally and functionally (e.g. L125R). How such mutants
cause RP is even more intriguing.
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Chapter 2
PURIFICATION AND CHARACTERIZATION
OF BOVINE OPSIN EXPRESSED IN INSECT CELLS
2.1 Introduction
In hopes of expressing large quantites of opsin, the synthetic
bovine opsin gene was expressed in Spodoptera frugiperda (Sf9) insect
cells. Previously, opsin has been expressed in COS-1 cells (Oprian et
al., 1987), 293S cells (Nathans et al., 1989), CHO cells (Weiss et al.,
1990), oocytes (Khorana et al., 1988) and by in vitro methods (
Zozulya et al., 1990). In transient expression studies COS-1 and 293S
cells synthesize similar amounts of wild-type opsin, approximately 10
gg/ 1.25 X 107 cells. However, in cells that have the opsin gene
integrated within the chromosomal DNA i.e. stable cell lines such as
CHO cells, the amount of protein is significantly less, about 20 ng/107
cells. The one advantage of this expression system is the cells can
easily be grown in suspension.
Insect cells have become a popular transient expression system
because of the large amounts of protein that are synthesized. For
soluble proteins up to 500 mg/10 9 cells is made (Luckow and
Summers, 1988). So far, only a few integral membrane proteins have
been expressed in Sf9 cells (e.g. multidrug transporter (Germann et al.,
1990), -adrenergic receptor (George et al., 1989)). In all cases the
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levels of expression are much lower than for soluble proteins. For
example, the P3-adrenergic receptor, a 7 membrane-spanning segment
protein like rhodopsin, is expressed at 1.5 tg/ 109 cells.
In this chapter the time course of expression, quantitation,
purification protocol, structural characterization and functional activity
of rhodopsin expressed in Sf9 cells is described.
2.2 MATERIALS AND METHODS
2.2.1 Materials
Sf9 cells were purchased from American Tissue Type Collection.
Insect cell media were purchased from JRH Scientific. Serum was from
Hyclone. N-glycosidase F and endoglycosidase H were from Boehringer
Mannheim. [9, 10- 3 H] Palmitic acid and [y-3 2 p] GTP were from New
England Nuclear. All detergents were purchased from Sigma and then
purified, except for dodecyl maltoside which was purchased from
Anatrace. The mouse monoclonal antibodies, 1D4 and 4D2, and the
polyclonal rabbit anti-opsin antibodies were prepared previously in
our laboratory. 11-cis Retinal was a generous gift of Dr. Peter Sorter
(Hoffman-LaRoche).
2.2.2 Construction of pVL1393-rho and Purification of
Recombinant Viral Particle
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From the eukaryotic expression vector pMT4 the synthetic
bovine opsin gene was isolated as an EcoRI-NotI restriction fragment
and cloned in the polylinker region of pVL1393- downstream from the
polyhedrin promoter (Figure 2-1). This new construct, pVL1393-rho,
was co-transfected with the wild type baculovirus into insect cells by
the calcium phosphate method (Summers and Smith, 1987). Three
days post-infection the media bathing the tranfected cells was placed
into 96-well titre plates at various dilution. This media contained the
recombinant virus particle in which the opsin gene as well as the
polyhedrin promoter had integrated into the baculovirus genome of
Autographa californica nuclear polyhedrosis virus (AcMNPV) by
homologous recombination. A radioactive opsin probe was used to
hybridize the viral DNA adherent on the nitrocellulose filter. When a
positive colony was found it was further purified by successive limited
dilutions (Figure 2-2). Once this was acheived the viral titre was
determined by the method described by Summers and Smith (1987).
Briefly, cells were plated in 96-well plates and various dilution of the
recombinant virus were added to the wells. Three days post-infection
the cells were scored for the presence of inclusion bodies-a non-
refractile dense body found in the cytoplasm of insect cells that is
easily identified by light microscopy. From the viral dilution where
50% of the cells had inclusion bodies the titre was determined by the
equation: PFU (plaque forming unit)/ml= 1/dilution x number of
plaques x 1/(mls of inoculum/plate). Although this method does not
exactly determine the viral titre it can approximate it reasonably well.
The titre of the viral supernatants was consistently between 1-5 X 108
plaque forming units (viral particles)/ml.
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Figure 2-1 Schematic of the isolation of the recombinant baculovirus
containing the synthetic bovine opsin gene.
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Figure 2-2 Dot-blot hybridization of recombinant baculovirus with opsin
probe. The dilutions are as shown.
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2.2.3 Detergent Extraction
Seventy-two hours post-infection, 107 cells were spun down at
1000 rpms for 5 minutes. The cells were then solubilized in various
detergents at 2% final concentration with 0.1 mM PMSF for 30 minutes
at 4C. The samples were then spun at 100000g for 30 minutes at 4C.
Equal volumes of the clarified extract was then run on SDS-
polyacrylamide gels. The proteins were then transferred to
nitrocellulose and immunoblotted with 1D4, a C-terminal monoclonal
antibody, or 4D2, a N-terminal antibody.
2.2.4 Quantitation of Opsin from Whole Cell Extracts
1D4 was dried down on Immulon 2 polystyrene wells, 5 gg/well.
The wells were then blocked with a 3% BSA solution in PBS for 2 hours
at room temperature. Next the plates were washed with Buffer 1
(0.1% BSA, 0.1% LM in PBS) 3 times with 300 gils. The wells were filled
with 100 gls of Buffer 1 and 100 gtls of purified ROS rhodopsin (0.9
gg/100 ls) was added. 100 tls of a 1/20 dilution of clarified insect
cell extract, solubilized either in 2% DTAB or 2% LM, was added to
separate wells. Serial two-fold dilutions were then made. The opsin
in each well was allowed to bind to 1D4 overnight at room
temperature with mild agitation. The next day the wells were
emptied and washed with Buffer I three times. A 1/7000 dilution of
a rabbit anti-opsin polyclonal antibody was added and the microtitre
plates were again incubated at room temperature overnight. The
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wells were again emptied and washed 3 times with buffer 1. A
1/5000 dilution of a goat anti-rabbit IgG conjugated to horseradish
peroxidase was added to the wells and allowed to bind at room
temperature for 2 hours. The wells were decanted and washed 3
times with Buffer 1. 150 gls of the chromogenic substrate, 10 mM
phosphate buffer pH 6.8, 0.1% aminosalisylic acid and 0.01% hydrogen
peroxide was added for 45 minutes. Afterwards the reaction was
stopped with 75 gls of 3M NaOH. The plates were then scanned with
an ELISA reader at 450 nm.
2.2.5 Time Course of Expression
At various times post-infection 10 7 cells were spun down at
1000 rpms for 5 minutes. The cell pellet was solubilized with 1%
dodecyl maltoside for 30 minutes at 4C in the presence of 0.1 mM
PMSF. The insoluble debris was pelleted at 100000g for 30 minutes at
4°C. The supernatant, containing solubilized opsin was loaded on 10%
SDS-PAGE and immunoblotted with either 1D4 or 4D2. The multiplicity
of infection (MOI), the number of viral particles to the number of
insect cells, was also varied to determine if it also had any effect on
expression.
2.2.6 Glycosylation of Insect Cell Opsin
Solubilized opsin, as mentioned above, was deglycosylated with
N-glycosidase F in the presence of 1% SDS and 2 mM EDTA. After
incubation at 37°C for 16 hours the samples were run on 10% SDS-
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polyacrylamide gels and probed with 1D4 after transferring the
proteins onto nitrocellulose. The solubilized opsin was also incubated
with endoglycosidase H, an enzyme that recognizes high mannose
structures associated with proteins retained in the ER, in 10 mM Tris
pH 7.5. Finally, the Boehringer Mannheim Glycokit was used to assess
the presence of mannose, sialic acid or O-linked glycosylation. This kit
contains primary antibodies to the sugar moieties mentioned above.
These antibodies are couples to digoxigenin. A secondary antibody
which is directed against digoxigenin and is also coupled to alkaline
phosphatase. After sequential incubation with the primary and
secondary antibody this system can then be used for standard
immunoblotting.
2.2.7 Palmitoylation of insect cell opsin
Twenty four hours post-infection 107 cells were spun down at
1000 rpm and the cell pellet was brought up in 1 ml of Grace's insect
cell media, without 10% fetal bovine serum, for one hour. [3 H] -
Palmitic acid, 150 Ci, was added for an additional 30 minutes.
Thereafter the cells were immediately pelleted, solubilized with 1%
dodecyl maltoside for 30 minutes at 4C in the presence of 0.1 mM
PMSF. The solubilized cells were then spun at 100000g for 30 minutes
and the clarified supernatant was allowed to bind to a Sepharose 4B-
1D4 antibody column. After 4 hours the resin was washed 5 times
(150 column volumes) with 10 ms of 0.1% LM in PBS. Opsin was then
eluted with 35 gM of a peptide consisting of the carboxy terminal 18
amino acid of bovine rhodopsin. The purified opsin was run on 10%
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SDS-polyacrylamide gels and subsequently flurographed. To cleave
the thioester linkage between the palmitoyl group and cysteine the
labelled opsin was incubated for 30 minutes at room temeperature
with 100 mM NH2OH pH 7.0. This protein was also run on SDS-
polyacrylamide gels as well.
2.2.8 Whole Cell Regeneration and Purification of
Rhodopsin
Three days post-infection 109 cells (approximately 1 litre),
were pelleted at 5000 rpms for 20 minutes at 4C. The pellet was
brought up in 9 mls of ice-cold PBS. In the dark, 1-cis retinal was
added to a final concentration of 2.5 t M and incubated with the cells
for 3 hours. The cells were then solubilized with 1% LM in the
presence of 0.1 mM PMSF and immunoaffinity purified as detailed
above. The UV/visible spectra of the purified samples were then
taken on a Perkin Elmer dual beam spectrophotometer.
2.2.9 Membrane Isolation and Purification of Rhodopsin
After harvesting and pelleting the infected insect cells at 3 days
post-infection they were resuspended in ice-cold hypotonic lysis
buffer, consisting of 5 mM phosphate buffer pH 6.8. The cells were
further disrupted with a teflon douncer, 10 strokes per sample. The
homogenate was spun at 100000g for 30 minutes at 4C. The
resulting membrane pellet was resuspended in cold PBS and layered
on top of a 20/50% (w/v) discontinuous sucrose gradient. The
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gradients were spun at 100000g for 30 minutes at 4C. The white
fluffy band at the interface was removed with a 16 gauge needle. The
membranes were washed with 12X volume of PBS and spun at
100000g for 30 minutes at 4C. The membrane pellet was brought up
in 9 mls of ice-cold PBS and regenerated for 2 hours at 4C with 11-
cis retinal at a final concentration of 5 CtM. The membranes were then
solubilized and purified as previously described. The UV/visible
spectrum was then taken.
2.2.9 Purification of Rhodopsin and Transducin from
Bovine Retinas
Rod outer segments were prepared from retinas by the method
of Hong and Hubbell (1973) as modified by Fung et al. (1981).
Rhodopsin and transducin were purified by the well established
procedures of Litman (1982) and Fung et al. (1981) respectively.
2.2.10 Transducin Activation
ROS and insect cell rhodopsin were assayed for their ability to
activate the GTPase activity of transducin upon light activation. The
assay cocktail included: 20 mM Tris pH 7.5, 100 mM NaCI, 5 mM
MgC12, 0.1 mM EDTA, 1 mM DTT, 0.1% LM, 1.32 tM [y- 3 2 P]-GTP (1-20
Ci/mmol), 145 pmol of transducin and 5 pmol of rhodopsin. The
reaction mixture, excluding GTP, was illuminated for two minutes.
Afterwards the assay was initiated by adding the radioactive GTP. At
various times after the reaction was inititiated aliquots were removed
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and the inorganic phosphate was complexed with molybdinum and
extracted into an organic phase.
2.3 RESULTS
2.3.1 Detergent Extraction
To determine which detergent or detergents would extract the
most opsin, insect cells were solubilized with a whole battery of
detergents, run on SDS-polyacrylamide gels and subsequently
immunoblotted. From the intensities of the opsin bands shown in
Figure 2-3 2% DTAB appears to solubilize the greatest amount of
opsin. DTAB also was able to solubilize whole insect cells the most
efficiently because the 100000g membrane pellet was the smallest
with this detergent. However when 1% DTAB was used later on for
purifying regenerated rhodopsin no chromophore was observed
(Figure 2-3). This suggests rhodopsin (i.e. the Schiff base linkage) is
unstable in it. Qualitatively the amount of opsin solubilized by DM is
less than that with DTAB (Figure 2-3). But from our laboratory's and
other workers' experience wild type rhodopsin was most stable in this
detergent (DeGrip 1982, Oprianet al., 1987). In all subsequent
experiments this mild detergent was used in purifying rhodopsin.
2.3.2 Quantitation of Opsin
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FiFure 2-3 A) Detergent extraction of opsin expressed in insect cells.
10 were solubilized in 2% of the detergents listed and an equal volume
was loaded onto a 10% SDS-polyacrylamide gel and subsequently
immunoblotted with ID4, a monoclonal antibody to rhodopsin; B) UV /
visible absorption spectra of opsin regenerated with 11-cis retinal and
solubilized with 1% DTAB.
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The standard curve for the rhodopsin sandwich ELISA assay is
shown in the top panel of Figure 2-4. With this simple assay it is
possible to detect as little as 10 ng of opsin. From this standard curve
the amount of opsin produced by Sf9 cells can be easily calculated.
The values shown in Table 2-1 are the average of three separate
measurements. It is clear the amount of opsin solubilized by DTAB is
greater than by LM. DTAB may more effectively solubilize all
compartments of insect cells including the ER where partially folded
opsin is most likely present. As mentioned above rhodopsin
solubilized in DTAB is less stable during the whole cell purification
protocol than in LM.
2.3.3 MOI and Time Course of Expression
To study the optimal MOI for expression of opsin insect cells
were infected at various MOI's. The cells were then solubilized with
LM or DTAB at various times post-infection and the clarified extracts
were then run on 10% gels. As seen in Figure 2-5 at 24 hours at MOI's
of 5, 10 or 20 only two bands are apparent. As will be discussed later
the faster running band represents unglycosylated opsin while the
upper band represents the fully glycosylated form. Varying the MOI's
had no effect on the amount of unglycosylated opsin being expressed.
At 40 and 72 hours post-infection the intensity of these bands does
not appreciably change. However there are some bands at lower
molecular weights. These most likely represent degradation products.
When the same gels are immunoblotted with 4D2, an N-terminus
monoclonal antibody, the same pattern is observed suggesting both
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the N and C- terminii are intact on the glycosylated and
unglycosylated forms. Cells harvested at 24 hours post-infection
(infected at an MOI=5) were regenerated with 11-cis retinal and
purified. No 500 nm chromophore was observed (Figure 2-6). The
maximal amount of 500 nm species was observed at 72 hours,
consistent with the expression of functional K+ channel in insect cells
(Klaiber et al., 1990).
Post Translational Modifications
2.3.4 Glycosylation
Insect cell has N-linked glycosylation like ROS rhodopsin. As
shown in Figure 2-7, the band migrating with ROS rhodopsin is
sensitive to N- glycosidase F. This species is also partially sensitive to
endoglycosidase H. There is no evidence of galactose or sialic acid
associated with insect cell opsin (Figure 2-8) although insect cells are
capable of complex glycosylation (Jarvis and Summers, 1989, Davidson
et al., 1990).
2.3.5 Palmitoylation
ROS rhodopsin is palmitoylated at cys322 and cys323
(Ovchinnokov et al., 1988, Karnik et al., 1993). To examine if insect
cell opsin is also palmitoylated a [ 3 H]-palmitic acid labelling
experiment was done. The fluorogram in Figure 2-9 shows the fully
glycosylated species incorporates palmitic acid. The unglycosylated
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Figure 2-6 UV / visible absorption spectra of regenerated insect cell
opsin 24 and 48 hrs post-infection.
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Figure 2-7 Sensitivity of insect cell opsin to N-glycosidase F. ROS
rhodopsin and insect cell opsin were solubilized in 1% DM and
incubated with PNGase F for 16 hrs at 37°C. The samples were then
loaded onto a 10% SDS-polyacrylamide, transferred to nitrocellulose and
then probed with ID4. Lane 1 = ROS rhodopsin - PNGase F; Lane 2
= ROS rhodopsin + PNGase F; Lane 3 = insect cell opsin - PNGase
F; Lane 4 = insect cell opsin + PNGase F.
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Figure 2-9 Palmitoylation of insect cell opsin. As detailed in the
Materials and Methods section, [3 H]-palmitic acid labelled insect cell
opsin was immunoaffinity purified, loaded onto a 10% SDS-polyacryla-
mide gel and subsequently fluorographed. Lane 1 = [3H]-palmitic acid
labelled insect cell opsin incubated with 100 mM NH2OH pH 7.0 for 1
hour at room temperature. Lane 2 = untreated labelled insect cell
opsin.
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species does not. The thioester bond can be cleaved with neutral
hydroxylamine. The absence of these covalent modifications suggest
the unglycosylated, unpalmitoylated form is either denatured and/or
selectively retained in the ER; since these covalent modifications occur
in that compartment.
2.3.6 Purification
When whole cells were regenerated, solubilized and purified the
best spectral ratio obtained was A 2 8 0 /A 5 0 0 = 3.0. This was done at
MOI= 5 and at MOI= 10, as shown in Figure 2-10. Rhodopsin purified
from the rod outer segment has a ratio of 1.60 This is considered
spectrally pure rhodopsin. When the insect cell rhodopsin was run on
gels two bands were seen on Western blots corresponding to the
mature and unglycosylated species (Figure 2-11). Silver stained gels
also revealed these bands as well as other higher molecular weight
proteins (Figure 2-11). Various other methods were tried to improve
the spectral ratio including a tandem two-column concanavalin A (a
lectin column which recognizes glycoproteins having high mannose
structures) followed by the 1D4 antibody column procedure. None of
them improved the spectral ratio. However, a crude membrane
preparation protocol resulted in spectrally pure rhodopsin with a ratio
of 1.65 (Figure 2-10). This purification method yielded 30 g/10 9
cells; a recovery of approximately 1% of the total opsin present in
whole cells. Total opsin includes both the mature and immature
forms. Figure 2-12 shows an immunoblot of each step in the
purification; equivalent volumes at each step were loaded into
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Figure 2-11 Gel characteristics of insect cell rhodopsin purified to a
ratio of 3.0. A) Western blot demonstrating the presence of both fully
glycosylated and unglycosylated opsin showing: Lane 1 = 10 ils of
eluate; Lane 2 = 25 uls of eluate; Lane 3 = 50 ls of eluate; Lane 4
= ROS rhodopsin. B) Silver stain of same sample showing both the
unglycosylated and glycosylated form, as well as other lower MW
species as follows: Lane 1 = 10 dtls of eluate; Lane 2 = 25 j4s of
eluate.
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successive lanes. All of the unglycosylated opsin was separated from
the glycosylated form at the sucrose gradient step. The purified,
eluted protein ran as a single band on both immunoblots and silver
stained gels (Figure 2-12) corresponding to the glycosylated species-
no unglycosylated opsin was detected.
2.3.7 Functional Activity
As shown in Figure 2-13, insect cell rhodopsin activated
transducin to about 70% of the value for ROS rhodopsin. This activity
was similar to the rhodopsin isolated from COS-1 cells (Oprian et al.,
1985).
2.4 DISCUSSION
Rhodopsin has been expressed in Sf9 insect cells under the
control of the polyhedrin promoter of baculovirus. The protein
expressed has been fractionated by a crude membrane preparation,
reconstituted with 11-cis retinal and immunoaffinity purified to a
spectral ratio of 1.65. Although other membrane proteins (e.g.
mutidrug transporter, the -adrenergic receptor) have been expressed
in insect cells this is the first time an integral membrane protein has
been completely purified from these cells. In those cases the total
yield was comparable to what was observed for opsin. Opsin has been
previously expressed in Sf9 cells but no purification was acheived nor
any spectra shown nor any functional characterization done (Jansen et
al., 1988). From the present studies opsin is first synthesized between
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Figure 2-13 Light-dependent transducin activation of ROS and insect
cell rhodopsin. As detailed in Materials and Methods section, ROS
rhodopsin and insect cell rhodopsin were incubated with transducin and
[32P]-GTP. At various times after illumination, samples were removed
and the amount of Pi released was quantitated. O = ROS rhodopsin +
hv; = insect cell rhodopsin + hv; · = ROS rhodopsin - ho; a =
insect cell rhodopsin - hv.
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18 to 24 hours post-infection at MOI's of 5, 10 and 20. Even though
protein is detectable by immunoblots at these early times, the protein
which is finally purified does not absorb at 500 nm. During these
early times opsin may be in a partially folded state and thus can not
stably bind 11-cis retinal. At any MOI or at any given time
unglycosylated opsin was always found.
Insect cell opsin has both N-linked glycosylation and
palmitoylation. ROS rhodopsin is glycosylated at asn2 and asn15
(Fukuda et al., 1979, Schichi et al., 1980). At both sites there are high
mannose structures which are partially sensitive to endoglycosidase H
suggesting that complex or hybrid carbohydrate structures are present
(Kornfeld and Kornfeld, 1985). The glycosylated form of insect cell
opsin is also partially sensitive to endoglycosidase H suggesting that
some fraction of the that species has a high mannose structure. The
remainder must have hybrid or complex structures, consistent with
recent findings which demonstrated insect cells can trim and add
carbohydrates like mammalian cells (Davidson et al., 1991). ROS
rhodopsin is also known to be palmitoylated at cys322 and cys323.
The palmitoylation of insect cell opsin is the first demonstration of
fatty acylation in insect cells. It is believed palmitoylation occurs in
the late ER or early Golgi. Insect cell opsin must be transported at
least to those organelles. From fluorescence activated cell sorting
(FACS) insect cell opsin was found at the cell surface and oriented
analogously to that found in COS-1 cells.
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Unlike COS cell opsin, insect cell rhodopsin can not be purified by
whole cell solubilization and immunoaffinity chromatography. The
best spectral ratios ontained by this method was 3.0 regardless of the
MOI. When run on SDS-polyacrylamide gels this sample consisted of a
fully glycosylated and unglycosylated species. The high spectral ratio
reflects the presence of a fraction of purified opsin that does not bind
11 -cis retinal- the unglycosylated species. However, when a crude
plasma membrane preparation was regenerated, solubilized and
immunoaffinity purified a spectral ratio of 1.65 was acheived. The
recovery was onlyl%. This species can activate transducin at levels
comparable to ROS rhodopsin. No unglycosylated opsin was seen on
immunoblots or silver stained gels. The unglycosylated form was also
the form that is not palmitoylated. Taken together this suggests the
unglycosylated, unpalmitoylated species is partially or fully denatured
such that the retinal binding pocket is poorly formed.
Insect cell rhodopsin is similar to ROS rhodopsin. Spectrally it
has a ratio of 1.65 and is glycosylated and palmitoylated. It may be
the polyhedrin promoter is so strong that far more opsin is translated
than can be accomodated by the post translational modification
machinery, as evidenced by the the large amount of the unmodified,
denatured protein found at even the earliest times of expression. It
may be possible to express more of the folded form of the protein by
driving expression from weaker promoters (Thiem and Miller, 1990).
The one major advantage of insect cells is the ease of scale up. Since
Sf9 cells can survive in suspension, large amount of cells at high
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density can be grown, infected and the expressed opsin can be
purified by the methods described.
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Chapter 3
THE ROLE OF N-LINKED GLYCOSYLATION IN RHODOPSIN
STRUCTURE AND FUNCTION
3.1 INTRODUCTION
Asparagine-linked glycosylation of membrane and secreted
proteins is frequently observed, although the functions that
glycosylation may serve are not clear (Hubbard and Ivatt, 1981;
Kornfeld and Kornfeld, 1985). It occurs at the tripeptide sequence
asn-X-ser/thr where X is any amino acid except proline (Hubbard and
Ivatt, 1981). For example, Rothman and Lodish (1977) showed that
for in vitro insertion of the VSV G-protein into microsomal membranes
N-linked glycosylation was necessary. In an in vivo study of the
same protein, Machamer et al. (1990) found that inhibition of
glycosylation by tunicamycin (TM) prevented transport of the protein
to the cell surface. Furthermore, the unglycosylated protein was
associated with Bip, a resident ER-protein known to recognize and bind
misfolded proteins. On the other hand Owen et al . (1980) found that
N-linked glycosylation of the HLA A and B antigens was not required
for appropriate insertion into membranes and transport to the cell
surface. In another study the type A natriuretic peptide receptor has
also shown the requirment of proper glycosylation (and
phosphorylation) for hormone-stimulated guanylyl cylase activity
(Koller et al., 1993). Further, when the P-adrenergic receptor, a
member of a superfamily of G protein-coupled integral membrane
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proteins, was expressed in the presence of TM, the unglycosylated
protein bound to ligands but only inefficiently activated its
corresponding effector phosphodiesterase (George et al., 1986; Boege
et al., 1988; Dixon et al., 1988).
Bovine rhodopsin, as isolated from rod cell outer segments, is
glycosylated at asn2 and asn15 by the heaxasaccharide sequence
G1NAc-GlNAc-Man-Man-Man-GlNAc (Fukuda et al., 1979; Shichi et al.,
1980) (Figure 3-1 and Figure 3-2). Fliester and Basinger (1985)
attempted to study the role of rhodopsin glycosylation in frog retina
by inhibiting glycosylation with TM. Little opsin was found in the rod
outer segment. Thus, in analogy with other findings, glycosylation
appeared to serve as a transport signal. In structure-function studies
of rhodopsin, our laboratory is using COS-1 cells to express wild-type
and site-specific mutants of rhodopsin. Using this system, the bovine
rhodopsin gene was expressed in the presence of TM. Glycosylation
was completely abolished. The opsin expressed was palmitoylated,
transported to the cell surface and on incubation with 11-cis retinal,
fully regenerated the characteristic chromophore (max= 500 nm).
These properties demonstrated the retinal binding pocket was
correctly assembled and glycosylation was neither required for folding
nor for transport. The most significant observation was that following
illumination, the TM-rhodopsin was 10% less efficient in triggering
transducin, even though the mIIl half-life was the same as wild type.
This suggests glycosylation effects the binding interaction between
rhodopsin and transducin.
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Figure 3-1 A) Synthetic pathway of dolichol diphosphooligosaccharide.
B) The structure of oligosaccharides isolated from bovine rhodopsin.
Oligosaccharide A is the major fraction. The amide of asparagine is
linked to C-2 of the terminal N-acetylglucosamine.
73
A
GOP -a
GOP-Man
I
D LI) N
< . O- Z w'
U) , , J
~~~~~.I 
zZ
I) cr-
Oo yr r(_0I 00
O ~ LL
!o -o
E o> 
0
n
L U CL >
o Zoz -
W _ -
LL tOLin ,' C)IL w 
I 1n I1
r:
IL
Or}
a.
m
.O
>L >
#'CY
A (D
.1 (D
c E E
O sJ
O~~o 0
o
._ 
cD oO Qe
._ .oo
o, U-
_
r~.~,
0
¢j= e
r,~ q,)
_u 
o c2
M-
._S 
I
_j ,
c- - L 
< I
)
Q
74
q)
C,
I
!
>- tv
I
I 
In other experiments the asn2 and asn15 were replaced with
gln. The other amino acids involved in the tripeptide consensus
sequence were also substituted to understand if they were critical for
rhodopsin folding and function. It appears that asn2 and the amino
acids immediately adjacent to it are not so critical. The amino acid
asnI5 and its neighbors play an important role both in the structure
and function rhodopsin.
3.2 MATERIALS AND METHODS
3.2.1 Materials
Bovine retinas used for isolating ROS rhodopsin and transducin
were from J.A. Lawson Co. (Lincoln,NE). [9,10- 3 H]-Palmitic acid (60
Ci/mmol), D-[2 3 H]-mannose, (20 Ci/mmol), deoxyadenosine 5'-
[a[35S]-triphosphate ( 500 Ci/mmol), adenosine 5'.[y. 3 2 p]-
triphosphate and guanosine 5'[y-[35S]-triphosphate (1000 Ci/mmol)
were from NEN. Tunicamycin, GTPyS and N-glycosidase F were
purchased from Boehringer Mannheim. Hydroxylamine hydrochloride
was from Sigma and dodecyl maltoside was from Anatrace. Sequenase
(version 2.0) was from United States Biochemicals. DNA purification
kits were from Qiagen. Nitrocellulose filters (HAWP25) were from
Millipore. 11-cis Retinal was a generous gift of Dr. P. Sorter
(Hoffman-La Roche) and Dr. R. Crouch (Medical University of South
Carolina and the National Eye Institute).
3.2.2 Construction of Rhodopsin Mutants
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All mutants were prepared by cassette (fragment) replacement
in the synthetic opsin gene. All the oligonucleotides used for the
construction of the mutants were synthesized on an Applied
Biosystems 380B DNA synthesizer and purified as previously
described (Ferretti et al., 1986). The mutants at asn2 and gly3 were
made by codon replacements in the EcoRI-FspI fragment of the
synthetic opsin gene. The mutants at asnl5, ala, cys, glu, lys, arg and
at lys16, cys and pro, were made by codon replacements in the KpnI-
FspI fragment in the synthetic gene. All mutants were constructed
with the appropriate DNA duplex containing the alterred codon. All
mutations were confirmed by dideoxynucleotide sequencing of
purified plasmid DNA (Sanger et al., 1977).
3.2.3 Expression and Purification of Mutants
Transient transfection of COS-1 cells was done by the DEAE-
dextran method (Kaufman and Murtha, 1987). Briefly, COS-1 cells
were plated at a density of 1.25-1.5 X 107 cells per 150 X 25 mm
culture plates. 14 hours later the cells were washed in 10 ms serum-
free media (Delbecco's Modified Eagle's Media (DMEM)) twice. 12.5 gg
of purified plasmid DNA and DEAE-dextran (0.25 mg/ml final
concentration) in DMEM were added to the cells for 6 hours.
Thereafter the cells were washed once with DMEM before adding
chloroquine (0.1 mM final) in complete media: DMEM plus 10% fetal
bovine serum (Luthman and Magnusson, 1983). The cells were then
washed twice with DMEM and complete media was added. The next
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day the media was changed again. When tunicamycin was used it was
added at 0.8 pgg/ml immediately after the chloroquine step. The cells
were harvested 60-70 hours after transfection, washed with cold PBS (
10 mM phosphate buffer pH 7.0, 150 mM NaCI) and incubated with 5
gM 11-cis retinal for 3 hours at 4C in the dark. After solubilization
in 1% DM and 0.1 mM PMSF the rhodopsin was immunoaffinity
purified on 1D4-Sepharose as described previously (see previous
chapter). The resin was washed (150-200 column volumes) with (i)
10 mM Tris (pH 7.0) containing 150 mM NaCI and 0.1% LM or (ii) 2
mM phosphate buffer pH 6.0 containing 0.1% LM. The rhodopsin was
eluted with 35 pgM with a peptide corresponding to thel8 amino acids
at the carboxy terminus of bovine rhodopsin. ROS rhodopsin was
purified by the same procedure. Rhodopsin preparations typically had
a UV/visible absorbance ratio of A28 0 /A 50 0 of 1.6-2.0. The eluted
rhodopsin was analyzed by SDS/PAGE with a 5% stacking and a 10% or
12% resolving gel (Laemmli, 1970).
3.2.4 In vivo Labelling of Opsin in COS-1 Cells with 3 H-
Mannose and 3 H-Palmitic Acid
[3 H]-Mannose incorporation was tested as follows: Forty-eight
hours after transfection, the COS cells in 150 mm plates were washed
twice with DMEM. The cells were then incubated in glucose-free
DMEM for 1 hour. [ 3 H]-Mannose (100 Ci/ml) was added and after 1.5
hours, the cells were harvested. The opsin was purified as detailed
above.
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For [ 3 H]-Palmitic acid labelling 48 hours post-tranfection COS
cells were starved in serum free media for 12 hours. Subsequently
the cells were incubated for 30 minutes at 37°C in media containing
1% fetal calf serum and then for an additional 2 hours in the same
media with [ 3 H]-palmitic acid (100 Ci/ml). Thereafter the cells were
harvested and the opsin was purified.
3.2.5 Molar Extinction Coefficients
Extinction coeffients were determined by acid denaturation of
each mutant opsin to give a 440-nm peak. The ratio of absorption at
the Xmax in the dark to the absorption at 440 nm after acid treatment
in the dark was compared to that of rhodopsin. The extinction
coefficient of rhodopsin was assumed to be 42,700 M-lcm -1 (Hong
and Hubbell, 1972).
3.2.6 Binding and Activation of Transducin
Transducin was prepared by the well-established methods of
Fung et al. (1981). The ability of wild-type, wild type(TM) and the
mutant rhodopsins was measured by the GTP-GDP exchange assay
(Wessling-Resnick and Johnson, 1987; Nakayama and Khorana, 1991).
For this assay the reaction mixtures contained 0-5 pmoles of pH 6.0-
purified wild-type, wild-type(TM) or mutant rhodopsin 4 M
transducin and 10 M guanosine 5'-[y-[ 3 5 S]thio]-triphosphate in 10
mM Tris pH 7.5/0.012% LM/100 mM NaCl/5 mM MgC12 /2 mM
dithiothreitol. The reaction mixtures were illuminated (>495 nm) for 2
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minutes at 20°C and allowed to remain in the dark for an additional
2.5 hours. Aliquots (100 .1) were removed and filtered through
nitrocellulose filters. The filters were washed five times in the
above-mentioned buffer without DM, dried and counted.
3.2.7 Metarhodopsin II half-life Determination
Purified wild-type rhodopsin and wild-type(TM) were
illuminated with light (>495 nm) for 2 minutes. At various times
thereafter an aliquot (150 1) was acidified to pH 2.0 with H 2 S0 4 ( 70
mM final). The spectra of each sample was then taken.
3.2.8 Phosphorylation of Rhodopsin and Mutants
Crude ROS extracts enriched for rhodopsin kinase were prepared
according to Sitaramaya (1980) with the modifications of Bhattacharya
et al. (1992). Briefly, ROS membranes were extracted with 70 mM
NaH2PO 4, pH 7.0, containing 200 mM KCI, 3mM EGTA, 3 mM DTT, and
50 g/ml of aprotinin, leupeptin, benzamidine-HC1 and pepstatin under
dim red light. The membranes were centrifuged, the supernatant
removed, and centrifuged to ensure all the rhodopsin was removed.
The supernatant, which served as the kinase preparation, was
concentrated 15-20-fold using Centricon CX30 immersable filters. To
250 pmols of purified pigments was added 200-250 units of kinase
extract ( 1 unit=1 mol Pi incorporated/mol ROS) and a solution of 70
mM NaH2 PO 4 , pH 7.0 containing [y-3 2 P]-ATP, 3mM MgC12, 150 M
DTT, and 10 p.M GTP. The final DM concentration was 0.012% (w/v)
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and the reaction volume was 2 mls. Phosphorylation was initiated by
illuminating the samples with a 300 W light source (>495 nm) at 200C.
At various times up to 60 minutes aliquots (200 gls were removed and
precipitated with 5 mM phosphoric acid containing 7% (w/v)
trichloroacetic acid (TCA) and 25 tg bovine serum albumin (BSA).
Samples phosphorylated under dim red light for 60 minutes served as
dark controls. After 2 hours at 4C, the samples were centrifuged and
the pellet washed 5 times with 1 ml of TCA. The pellets were
dissolved in 0.5 mls protosol and counted. The [ 3 2 p] (mol)
incorporated was calculated from the amount of acid-precipitable
counts and the specific activity of the [y-3 2 P]-ATP.
3.3 RESULTS
3.3.1 Replacement of Asn by Gin at Glycosylation Sites
in Rhodopsin
The first mutants to be constructed and expressed were N2Q,
N15Q and N2,15Q. The glutamine substitutions represent the most
conservative substitutions for asn. The mutant N2Q yielded nearly
comparable amounts of chromophore to wild type rhodopsin (Figure
3-3). However, the expression of the mutants N15Q and N2,15Q gave
much less opsin. Upon regeneration and purification at pH 7.0 in the
presence of 100 mM NaCI they showed poor spectral ratios,
A 2 8 0 /A 5 0 0 > 5.0.
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Figure 3-3 UV / vis absorption spectra of nonglycosylated wild-type
rhodopsin and glycosylation-site mutants. Opsin and opsin mutants
expressed in transiently transfected COS-1 cells were reconstituted with
11-cis-retinal, solubilized in DM, and immunopurified at pH 7.0 or pH
6.0 as indicated. Spectra recorded at 20°C in the dark are shown. The
absolute A280 values varied from 0.1 for glycosylated wild-type to 0.04
K16R mutant.
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Figure 3-4a shows an immunoblot of wild-type rhodopsin, the
gln mutants and their sensitivity to N-glycosidase F. The mutant N2Q
shows a glycosylation smear which migrates slightly faster than wild-
type. This is consistent with glycosylation at one site (asnl5) and not
the other (asn2) since the consensus sequence had been alterred
thereby abolishing N-linked glycosylation at the latter site. The other
mutants lack a smear and have a distinct intermediate band between
the mature form (highest MW band) and the unglycosylated form
(lowest MW form). This particular band may represent a partially
folded and/or partially glycosylated species. Except for N2,15Q the
other mutants collapse to a single band after incubation with N-
glycosidase F.
3.3.2 Sugar Labelling of Glycosylation Mutants
To demonstrate if these mutants can incorporate mannose, [3H] -
mannose was added to the transfected cells prior to purification. As
seen in the fluorogram in the of Figure 3-4b, wt, N2Q, N15Q, were
labelled wheras N2,15Q was not. This is consistent with there being
only two glycosylation sites in rhodopsin.
3.3.3 Cellular Localization of Mutants
As a qualitative measure of transport Figure 3-5 shows the
immunofluorescence staining pattern of these mutants. When
expressed, wt and N2Q were found mostly at the cell surface; the
mutants N15Q and N2,15Q were found in the perinuclear region.
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Figure 3-5 Cellular localization of glycosylated and nonglycosylated
opsins by immunofluorescence. A) Wild-type COS-1 cell opsin. B)
Wild-type COS-1 cell opsin expressed in the presence of TM. C)
Mutant opsin N15Q. D) Mutant opsin N2,15Q. Rhodamine-conjugated
goat anti-mouse antibody was used to probe for the mouse rho 4D2
rhodopsin monoclonal antibody. Arrows indicate surface of the COS-1
cells.
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Presumably they were retained in the ER. It seems when opsin is
translocated out of the ER its subsequent glycosylation causes a
characteristic smear. The smear represents microheterogeneity in
carbohydrate processing in the Golgi (Goochee et al., 1991). Mutants
which are retained do not acquire this smear and furthermore these
proteins show a distinct multi-band pattern on immunoblots.
3.3.4 Hydroxylamine Sensitivity of Mutants
To probe the stability of the 500 nm chromophore we examined
its sensitivity to hydroxylamine in the dark. It is known the color
pigments and certain rhodopsin mutants react with hydroxylamine in
the dark (Zhukovsky et al., 1992). Wild-type rhodopsin itself is not
sensitive to rhodopsin in the dark. As shown in Appendix 3 neither
N2Q, N15Q nor N2,15Q react with neutral hydroxylamine (100 mM
final) in the dark, suggesting that the ground (dark) state of these
mutants is equally unreactive as the wild-type. The photobleaching
behavior of the mutants N15Q and N2,15Q was however abnormal.
They appear to release all-trans retinal more quickly after alO second
illumination, indicating the ml species has a shorter half-life than
wild-type (Appendix 2). It appears glycosylation at asnl5 stabilizes
the photoactivated species mII.
3.3.5 Characterization of COS Cell Rhodopsin Expressed
in the Presence of Tunicamycin
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Tunicamycin has been used extensively by others to inhibit the
transfer of dolichol pyrophosphate-(GluNAc)2-Mang to an asparagine
residue which is part of the consensus tripeptide sequence for N-
linked glycosylation (Elbein, 1987). To study the effects of TM on
wild-type opsin, the concentration needed to inhibit glycosylation
without affecting the overall yield was first determined. At 0.8 g/ml
COS-1 cell opsin migrated as a single band of MW 33,000 daltons.
similar to N-glycosidase F-treated ROS rhodopsin. As shown in Figure
3-6a, the mobility of this species does not shift after treatment with
N-glycosidase F, unlike wild-type rhodopsin in the absence of TM. To
further demonstrate TM treated opsin was unglycosylated an attempt
was made to label it in vivo with [ 3 H]-mannose. The fluorogram in
Figure 3-6b shows wt(TM) does not incorporate the labelled sugar
even though the protein is observable by immunoblot. It had been
previously shown that wild-type COS opsin is palmitoylated and
transported to the cell surface. Figure 3-6c shows a fluorogram of wt
and wt(TM) labelled with [ 3 H]-palmitic acid, both are labelled.
Although the actual cellular compartment of palmitoylation is not
known with certainty, it is believed to occur in the "late" ER or early
Golgi. Figure 3-5 demonstrates by immunofluorescence that both wt
and wt(TM) reach the cell surface.
The UV/visible absorption spectra of regenerated, purified
unglycosylated opsin and glycosylated wild-type rhodopsin are shown
in the top two panels of Figure 3-3. Clearly the unglycosylated form is
able to form a 500 nm chromophore with a spectral ratio (1.7) similar
to the glycosylated form. Both species are resistant to hydroxylamine
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bleaching in the dark suggesting both chromophores are stable in the
absence of light (Appendix 3).
We tested the functional competence of unglycosylated
rhodopsin by examining its ability to bind and activate transducin by
using a GTPyS exchange assay. As seen in Figure 3-7 unglycosylated
opsin is less efficient in coupling to transducin than the glycosylated
form.
This difference is not due to a shorter mII half-life since the
tl/2's of unglycosylated rhodopsin is the same as the glycosylated
form as shown in Figure 3-8. Acid denaturation of rhodopsin upon
illumination results in an absorption spectrum with a maxima at 440
nm. This is typically what is found for a protonated Schiff base that
has no significant protein interactions. The acid denaturation assay
therefore monitors the rate of Schiff base hydrolysis, reflecting the
decay of mII. The mI half-life for both chromophores was
approximately 18 minutes.
3.3.6 Characterization of Other Glycosylation Site
Mutants
To further understand the role of the two glycosylation sites of
rhodopsin additional mutants were constructed at other amino acids in
the tripeptide consensus sequence. Gly3 was replaced with proline
since it is not tolerated in the second position of the consensus
tripeptide sequence. A cysteine mutant was also made at that site for
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Figure 3-7 Transducin activation by nonglycosylated wild-type
rhodopsin and glycosylation-site mutants. The activation of transducinas a function of rhodopsin concentration was measured by using aGTP[yS] filter-binding assay. The amount of pigment used in the assays
was based on the molar extinction coefficient. Wild-type COS-1 cell
rhodopsin [Rho (COS)] expressed in the absence (0) and presence ofTM (); N2Q (); N15Q (a); T17M (); and T17V ().
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Figure 3-8 UV / vis absorption spectra of glycosylated and
nonglycosylated wild-type and N15Q rhodopsins upon illumination. The
pH 6.0-purified pigments were illuminated (> 495 nm) for 10 s at 20°C
and subsequently denatured at the indicated time periods by the addition
of 2 M H2 SO4 to a final pH of 1.9.
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future crosslinking and derivatization studies. Additional
substitutions at asn15 were made to examine if residues other than
glutamine would be tolerated at those positions. N15A, N15C, K16C
were constructed and expressed to see if a smaller residue would
allow for correct and efficient folding of opsin. The mutants N15E,
N15K, N15R and K16R were made to see if charge substitutions would
be tolerated.
These additional mutants can be classified by the amount of
A500 and their spectral ratio. Those mutants near the N-terminus
N2Q, G3C, G3P were most similar to wild-type in both yield and
spectral ratio (Figure 3-3 and Appendix 1).
In contrast, those mutants at the second glycosylation site
showed quite different spectral characteristics. All the mutants at N15
were similar to N15Q, i.e. low chromophore yields and high spectral
ratios. The two mutants at K16 did not regenerate at all. The spectra
of K16C is shown in Figure 3-3. These opsins are not sensitive to
hydroxylamine in the dark. Nearly all of these mutants have
abnormal bleaching characteristics, similar to N15Q, indicating the mIIl
half-life is shorter in these mutants (Appendix 2). This is consistent
with these mutants being less efficient in triggering transducin
(Appendix 4).
3.3.7 Phosphorylation of wild-type rhodopsin, non-
glycosylated rhodopsin and glycosylation mutants
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Another assay to detect the difference in the mII-like
conformations of wt, wt(TM) and the mutants is in their ability to be
phosphorylated. As discussed in the introduction phosphorylation of
rhodopsin occurs as a mechanism by which the activated receptor is
turned off and eventually returned to the ground state. Figure 3-9
illustrates that at 60 minutes ROS rhodopsin and wt(COS) incorporate
about 4.5 moles of [3 2 p] per mole of protein whereas wt(TM) and
N15Q incorporate only 1 mole per mole and N2Q and T17M
incorporate about 2.5 moles per mole. This would suggest there is a
difference in the mlI-like state of wt(TM) since its mII t1/2 is similar
to wt(COS). In the case of the mutants the possibility exists there is a
difference in the mIT-like state since it is shorter lived. But whether
the actual conformation of those intermediates is different can not be
determined from these data.
3.4 DISCUSSION
As an integral membrane protein opsin must be transported
from the ER to the Golgi apparatus and eventually to the cell surface,
in COS cells, or to the outer segment of the rod cell. Along this
transport path it is covalently modified by the glycosylation and
palmitoylation enzymatic machinery. The first glycosylation step
occurs in the ER, probably as a cotranslational event (Hubbard and
Ivatt, 1981). It is believed that glycosylation can occur just as long
the site is available i.e. the site must be accessible before that region
folds (Hubbard and Ivatt, 1981). Using both site-specific mutagenesis
and tunicamycin the role of N-linked glycosylation in rhodopsin
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Figure 3-9 Phosphorylation of ROS rhodopsin, COS rhodopsin, wt(TM)
and mutants of rhodopsin. After illumination, phosphorylation was
initiated by adding rhodopsin kinase. After quenching and TCA
precipitation, the extent of phosphorylation at various times was
quantitated by measuring the amount of [32p] incorporated.
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structure and function has been studied. Conditions were established
whereby wild-type opsin could be expressed in the presence of
tunicamycin at a concentration that was not toxic to the cell nor that
drastically altered protein synthesis. At high concentrations TM is
known to block protein synthesis (Elbein, 1987).
The most important finding in this study of rhodopsin is
glycosylation is not required for the in vivo folding, assembly and
transport of opsin. Unglycosylated wild-type rhodopsin, wt(TM), is
palmitoylated further demonstrating it is similar in most aspects to
wild-type rhodopsin. However, unglycosylated rhodopsin is 1/10 less
efficient in triggering transducin as evidenced by a rightward shift of
the binding curve.
Complementing this approach, a series of mutants were
constructed and expressed to separately assess the role of
glycosylation at asn2 and asnl5. These mutants also delineated some
of the structural features of the N-terminus.
The UV/visible spectra of unglycosylated rhodopsin and the
mutants is a useful way to determine the ability of the protein to form
a correctly folded retinal binding pocket and its ability to stably bind
11-cis retinal. As such unglycosylated rhodopsin, N2Q, G3C and G3P
regenerated like wild-type. It appears glycosylation at asn2 is not
required for the folding or function of rhodopsin. However, all the
remaining mutants regenerated moderately or poorly as reflected by
the low absorbance at 500 nm and high A 2 8 0 /A 5 0 0 ratios. This
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suggests that some fraction of the immunoaffinity purified protein is
not able to bind 11-cis retinal via a stable Schiff base linkage. This
difference may reflect how efficiently these mutants are being folded
within the cell. When the mutants are purified at pH 6.0 in the
absence of salt, the spectral ratio is between 1.6-1.9. The low pH
elution, developed by Kevin Ridge in our laboratory, selectively
releases the folded form of of the mutants from the resin.
Previously in our lab Doi et al., (1991) demonstrated the
intradiscal region of rhodopsin is important for the proper assembly of
rhodopsin. Notably N-terminal deletion mutants showed the same
poor regeneration as the mutants at asnl5 and lys16. These residues
besides forming the glycosylation site also participate in the formation
of the intradiscal tertiary structure.
On immunoblots purified ROS rhodopsin migrates as a single
band. COS cell rhodopsin has a mature species comigrating with the
ROS form as well as a higher molecular weight glycosylation smear.
This mature form and the smear collapse to a single band when
incubated with N-glycosidase F. This deglycosylated opsin comigrates
with opsin expressed in the presence of TM. The mutant N2Q, as well
as G3C, G3P and T4K, has a mature form and smear that has a smaller
molecular weight than that observed with wild-type. This would
imply that the smear is associated with asnl5. Its presence is
correlated with the protein being transported to the cell surface. It
does not always correlate with the regenerability of a mutant but most
mutants that regenerate well have an associated smear.
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The other mutants do not have a glycosylation smear. They
have a multi-band pattern like those found with N15Q. As shown in
Figure 3-3, the intermediate and mature bands are sensitive to N-
glycosidase F. It may be these species represent a pool of opsin
intermediates in various compartments in the secretory pathway.
Alternatively, they could be folding intermediates that have had their
carbohydrates processed to varying extents. Or the muti-band pattern
could be the result of overexpressing the mutants in COS cells. But the
same pattern was found when these mutants were expressed in CHO
cells- a mammalian expression system that expresses proteins at
levels 1/10-1/100 of COS cells. The absence of muti-bands correlates
with good regenerability whereas its presence is associated with
mutants that regenerate poorly.
The double mutant N2,15Q has a multi-band pattern which is not
sensitive to N-glycosidase F. The same pattern is found when this
mutant is expressed in CHO cells. This mutant does not incorporate
radioactive mannose. Clearly, it does not have N-linked glycosylation.
The mutiple bands may represent various conformers of the protein or
even O-linked glycosylation at some accessible serine residues, such as
those found at the C-terminus.
The mutants N2Q, G3C and G3P were more similar to wild-type
rhodopsin in their ability to trigger transducin than the mutants at
asnl5. These mutants were about 1/100 less efficient in coupling to
transducin. Since these mutants released all-trans retinal much more
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readily than wild-type, directly suggesting a shorter metarhodopsin II
half-life, the difference in the binding efficiency probably reflects the
difference in the mlI t1/2's of wild-type and the mutants. Taken
together this data would indicate glycosylation at asnl5 may be
important for the stability of ml. The carbohydrate moiety at that
site may provide a certain protection to the retinyladene Schiff base in
the mI state.
Finally, the mutants at asn15 and lys16 demonstrated the
structural requirements at the N-terminus of the intradiscal region.
Even the most conservative mutation, N15Q, which differs from the
asn by only one carbon atom, lead to low expression and chromophore
levels. Other mutations at this site were not well tolerated as
measured by A 5 0 0 and the A 2 8 0 /A 5 0 0 ratio. The two mutants at
lys16 were even less tolerated- these mutant proteins could not even
bind 11-cis retinal. This would suggest the N-terminus is important
for the correct formation of the intradiscal tertiary structure.
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Chapter 4
STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF
RHODOPSIN MUTANTS ASSOCIATED WITH
AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA (ADRP)
4.1 INTRODUCTION
Retinitis Pigmentosa (RP) is a type of retinal degeneration.
Many different forms of this disease have been observed clinically
(Heckenlively, 1988). The hallmarks of this disease include
progressive nightblindness, rod cell degeneration often accompanied
by cone loss as well, and progressive decrease in ERG
(electroretinogram) potentials, reflecting a loss of overall retinal
function (Table 4-1 and Figure 4-1) (Driyja, 1992). RP is a hereditary
disease which can tranmitted as a X-linked, autosomal recessive or
autosomal dominant trait . Depending on the type of RP the clinical
course and severity of the disease is variable (Heckenlively, 1988).
Little is known about the pathogenesis or biochemistry of this disease.
Autosomal Dominant Retinitis Pigmentosa (ADRP) is a form of RP
which occurs in approximately 1/3000 live births in the United States.
Driyja et al. (1990a) described the first mutation, P23H, in the gene
encoding human rhodopsin associated with ADRP. Subsequently, this
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I. CLINICAL FEATURES OF RETINITIS PIGMENTOSA
A. Symptoms
1. Night blindness
2. Early loss of peripheral visual field
3. Late loss of central field as well
B. Signs
1. Pallid optic nerve head
2. Attenuated retinal vessels
3. Bone spicule pigmentary deposits in the periphery
4. Posterior subcapsular cataract
C. Electroretinographic abnormalities
1. Reduced amplitude of scotopic and photopic b-wave
2. Delay in time between flash of light and peak of b-wave
(delayed implicit time)
II. DISTRIBUTION OF CASES ACCORDING TO GENETIC
TYPE (based on ref. 12)
A. Autosomal dominant-43%
B. Autosomal recessive-20%
C. X-linked-8%
D. 'Isolate' (i.e. only one affected family member, possibly
representing autosomal recessive disease, but could also be
new dominant or X chromosome mutation)-23%
E. Undetermined (i.e. adopted, uncertain family history, etc.)-6%
Table 4-1 The clinical and epidemiological spectrum of retinitis
pigmentosa.
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A--Representative fundus photographs
from four patients with autosomal dominant
retinitis pigmentosa with a cytosine-to-ade-
nine transversion in codon 23 of the rhodop-
sin gene to show variability with respect to the
extent of intraretinal bone spicule pigmenta-
tion among patients with the same gene de-
fect.
B
1
2
3
4
Shown here are rod responses from a
normal individual and from RP patients. Tracing
1 is from a normal individual. Tracings 2 and 3
demonstrate reduced amplitude and delayed
responses from RP patients. Tracing 4 shows
an extinguished response from a patient with
advanced RP. The horizontal time base is 30
milliseconds per division. The vertical apli-
tude axis is 250 I.V per division for tracing 1
and 100 iLV per division for all other tracings.
30 ms per divbon
Figure 4-1 The funduscopic (A) and electroretinographic (B) features ofRP.
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group and others have discovered over 40 rhodopsin mutations in
ADRP (Driyja et al., 1990b; Driyja et al., 1990c; Sung et al., 1991;
Sheffield et al., 1991; Bhattacharya et al., 1991; Driyja, 1992). As of
now the list of mutations (Table 4-2) continues to grow somewhat
reminiscent of the mutations leading to hemoglobinopathies. Three of
the mutations are deletions; the remaining ones are single amino acid
substitutions. Some sites have multiple subtitutions (e.g. D190G,
D190N, D190Y); behaving as mutational hot spots. The mutations are
distributed throughout the protein in the intradiscal, transmembrane
and cytoplasmic regions (Figure 4-2). Most of them are clustered in
the intradiscal and transmembrane region. One mutation, COY
(Driyja, 1992), is at the conserved cysteine residue believed to be
disulfide bonded with cys187 (Karnik et al., 1988; Karnik and Khorana,'
1991).
There is great variability of the disease depending on the
rhodopsin mutation associated with ADRP. For example patients with
P23H mutations have a milder clinical course and thereby retain more
useful vision than those with the P347P mutation (Driyja, 1992). But
in the majority of the mutations described too few patients have been
studied to make meaningful clinical correlations with the natural
history and severity of the disease. As with other hereditary diseases
one may expect there should be variability even among patients with
a given mutations.
In this chapter the structure and function of most of these
mutant proteins is described. Additional mutant opsins near the sites
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Table 4-2 The mutations of opsin associated with ADRP.
Amino Acid #
4
17
23
28
45
51
53
58
68-71
87
89
90
106
110
125
Amino Acid Chg
T-K
T-M
P--H,L
Q-H
F-L
G-'R,V
P-R
T-R
aL,R,T,P
V-D
G-D
G--D
G-R,W
C--Y
L-R
Amino Acid #
135
167
171
178
181
186
190
211
256
296
344
345
347
Amino Acid Chg
R-.G,W
C-*R
PAL
Y-C
E-.V
S-P
D-G,N,Y
H--P
aI
K-*E
Q-stop
V-M
P-L,S
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of the ADRP mutations were also contructed and expressed. From all
these studies it is clear there is significant heterogeneity both
structurally and functionally among the rhodopsin mutants. Some
represent defects in folding as determined by their inability to
bindI l-cis retinal. Others are mutants which regenerate poorly and
have abnormal bleaching kinetics. Yet others are indistinguishable
from wild-type rhodopsin. Taken collectively there are probably
many different pathophysiological mechanisms by which these mutant
proteins cause RP.
4.2 MATERIALS AND METHODS
4.2.1 Materials
Bovine retinas used for the isolation of rhodopsin and transducin
were from J.A. Lawson Co. (Lincoln, NE). Deoxyadenosine 5 ' -
[a [3 5 S ] triphosphate (500 Ci/mmol) and guanosine 5'[y-
[35S]triphosphate (1000 Ci/mmol) were from NEN. GTPyS and
TritonX-114 were from Boehringer Mannheim. Dodecyl maltoside was
from Anatrace. Brefeldin A and cyanogen bromide activated
Sepharose 4B were from Sigma. Sequenase (version 2.0) was from
United States Biochemicals. DNA purification kits were from Qiagen.
Nitrocellulose filters (HAWP25) and PVDF membranes were from
Millipore. 11-cis Retinal was a generous gift from Dr. Peter Sorter
(Hoffman-LaRoche) and Dr. R. Crouch (Medical University of South
Carolina and the National Eye Institute). The antibody K16-50 was a
generous gift from the laboratory of Dr. P. Hargrave.
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of Rhodopsin Mutants
All mutants were prepared by cassette (fragment) replacement
in the synthetic opsin gene. All the oligonucleotides used for the
construction of the mutants were synthesized on a Applied Biosystems
380B DNA synthesizer and purified as previously described.
mutants were made by codon replacements in the appropriate
restriction fragments:
Mutant(s) Restriction Fragment
T4K,T17M,T17V KpnI-FspI
P23H,P23L FspI-BanII
Q28H,F45L FspI-BclI
G51R,G51V,P53R,T58R
A68-71
BclI-HindIII
HindIII-BglII
V87D,G89D,G9D0D
G106R,G106W,C110Y
L125R
R135L
C167R
P170L,P171L,A170-171
Y178C,E181K,S186P,G 188R
D190G,D190N,D190Y
H211P
I256A,A255-256
K296D,K296E,K296R
Q344stop,V345M,P347L,P347 S
BglII-NcoI*
NcoI-XhoI#
XhoI-PvuI
PvuI-AhaII
AhaII-XbaI
SfiI-ClaI
XbaI-ClaI
ClaI-AvaII
AvaII-MscI
NheI-MluI
ApaI-AatII
SalI-NotI
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The
4.2.2 Construction
-A
* These mutants were constructed in the expression/cloning vector
pSK. The opsin gene as an EcoRI-BamHI fragment was cloned
downstream from the CMV promoter in the vector pCMV5 (a gift of Dr.
David Russell, Southwestern Medical Center, Dallas, Texas). Another
feature of this vector is it contains the 5'-untranslated region of the
Alfalfa Mosaic Virus 4 RNA. This sequence acts as a translational
enhancer by decreasing the requirements for initiation factors in
protein synthesis (Andersson et al., !989). The utility of pSK lies in
that many more of the restriction sites found uniquely in the synthetic
gene are unique in the whole vector thereby making cloning in
different regions of the gene relatively easy. When the vector was
constructed the first 100 bp and last 100 bp of the synthetic gene
were sequenced. Many of the restriction sites found in the gene were
verified by appropriate enzymatic digestion. The expression levels of
wild-type opsin from pMT4 and pSK are the same.
#These mutants were first constructed and sequenced in the cloning
vector pOP3. This vector was constructed by a former post-doctoral
fellow in our laboratory, Dr. Barry Knox. The mutant opsin gene was
excised from this vector as an EcoRI-NotI fragment and ligated into
the EcoRI-NotI large fragment of pMT4. Before transfecting COS-1
cells with this vector the mutant gene was sequenced again to reverify
the presence of the mutation.
All mutations were confirmed by dideoxynucleotide sequencing of
plasmid DNA (Sanger et al., 1977).
4.2.3 Expression and Purification of Mutants
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All procedures for the culturing and transfection of COS-1 cells
has been previously described. The methods of immunoaffinity
purification have also been detailed as well. WIld-type rhodopsin was
also expressed in the presence of Brefeldin A (BFA). It was added to
the transfected cells immediately after the chloroquine incubation at a
concentration of 5.0 g/ml.
4.2.4 Binding and Activation of Transducin
Transducin was prepared by the methods of Fung et al. (1981).
The GTPyS exchange assays were done exactly as previously described.
4.2.5 Sodium Carbonate Extraction of Membranes
After transfecting and harvesting total cell membranes were
made by first resuspending the cell pellet in hypotonic buffer, 5 mM
Tris pH 7.0. The samples were then passed through a 28 gauge needle
6 times to completely disrupt the cells. The membranes were then
pelleted at 1000OOg for 40 minutes. The membrane pellets were
resuspended in 2.0 mls of 0.1 M sodium carbonate pH1 .3. To insure
complete resuspension of the membranes they were again passed
through a 28 gauge needle 6 times. The membranes were then
incubated at 4C for 30 minutes with gentle agitation. They were
pelleted at 150000g for 40 minutes. The supernatant containing the
extracted proteins was saved. The membranes were then extracted
once more. The two supernatants were pooled and the pH neutralized
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to 7.0 by the addition of 1 N HCL. DM was added to a final
concentration of 0.1% to prevent possible aggregation and the opsin
was immunoaffinity purified on 1D4-Sepharose 4B resin. The
remaining membrane pellet was solubilized with 1% DM and 0.1 mM
PMSF. The solubilized samples were then spun at 100000g for 30
minutes at 4C and the opsin purified. After elution from the column
equal amounts of the eluate were loaded on SDS-polyacrylamide gels
(Laemmli, 1970). The proteins on the gel were subsequently
transferred to PVDF membranes and immunoblotted with 4D2, an N-
terminal antibody.
4.2.6 Phase Separation of Proteins in TritonX-114
Solution
After transfecting and harvesting 1.25 X 107 COS-1 cells were
solubilized for 30 minutes at 4C with 2 mls of 1.0% TritonX-114 in
PBS plus 0.1 mM PMSF. Afterwards the sample was placed in a 37°C
waterbath for 5 minutes when a distinct oil-droplet like detergent rich
(lower) phase and an aqueous (upper) phase were discernable. The
samples were then spun at room temperature for 3 minutes at 500g in
a clinical centrifuge. The upper phase was removed and it was
extracted with 1.0% TritonX-114 as above. The two detergent-rich
phases were combined. Opsin was then purified from that fraction as
well as the aqueous phase. Equal volumes of the eluates were run on
SDS-polyacrlamide gels; the proteins were then immunoblotted as
mentioned above.
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4.2.8 Immunofluorescence Microscopy and
Fluorescence-Activated Cell Sorting (FACS)
COS-1 cells were transfected on microscope glass coverslips. 72
hours post-transfection the cells were washed twice with cold PBS and
then incubated for 5 minutes with ice-cold methanol and then for 5
minutes with ice-cold acetone. The fixed cells were then washed twice
with PBS and incubated for 2 hours with 4D2 (5 ,tg/ml) and 1% BSA in
PBS at room temperature. The cells were then washed with 1% BSA in
PBS twice and incubated for 1 hour with a 1:200 dilution of rhodamine
conjugated anti-mouse antibody. The unbound antibody was then
washed away with PBS and coverslips were mounted on glass slides.
For FACS studies exactly the same procedure was used except
the cells were were harvested and the antibody binding were done in
suspension. The live cells, those that excluded the vital dye propidium
iodide, were sorted at the core facility at the MIT Cancer Center.
4.3 RESULTS
A summary of the phenotypic characteristics of all the ADRP
mutants mentioned is shown in Table 4-3. The class I mutants are
those that are most similar to wild-type COS rhodopsin in their level of
expression, amount of chromophore regenerated, cell surface targeting
and glycosylation pattern. The class II mutants are those which are
expressed at low levels, do not form chromophore, are retained in the
endoplasmic reticulum and are abnormally glycosylated. The class III
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Table 4-3 ADRP Mutants Classified According to Their Phenotypes
Class I Class II Class III
F45L C167R T4K
T58R P171L T17M
L125R Y178C Q28H
R135G E181K G51R
D190G S186P G51V
D190N D190Y P53R
Q344stop H211P ,68-71
V345M K296E V87D
P347L G89D
P347S G90D
G106R
G106W
CllOY
1256 a
Legend: Class I closely resembles wild-type rhodopsin expressed in
COS cells. Thus, these mutants fold correctly to bind 11-cis-retinal and
form the characteristic rhodopsin chromophore. Class II mutants are
defective in folding and stay in endoplasmic reticulum. They do not bind
11-cis-retinal and regenerate the 500 nm-absorbing chrompphore only
partially.
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mutants are expressed at intermediate levels, form some
chromophore, are also retained in the endoplasmic reticulum and also
abnormally glycosylated. These mutants have abnormal bleaching
kinetics and also trigger transducin inefficiently. The mutants found
in each class are not spefically located to one region of the protein.
Below the mutants are discussed in detail by the region in which they
occur.
4.3.1 Mutants at the N-Terminus:
T4K,T17M,P23H,P23L,Q28H
Little is known about the length or structure of the N-terminal
tail of rhodopsin. It is believed to be exposed to the aqueous
environment (McDowell and Hargrave, 1992). All the mutants found-'
in this region of the protein yielded less chromophore than wild-type
after immunoaffinity purification (Figure 4-3). T4K, T17M and Q28H
all gave similar amounts of the protein relative to one another. The
mutants T4K and T17M are found at the two separate sites of
rhodopsin glycosylation. Both of them disrupt the consensus
tripeptide sequence required for N-linked glycosylation (asn-X-
thr/ser, where X is any amino acid except proline). As expected the
mature opsin of both mutants have slightly smaller molecular weights
(Mr= 37,000) than wild-type COS opsin. Another mutant, T17V, was
also made and expressed. It also regenerated like T17M (Figure 4-3).
All of these mutants when purified at pH 7.0 gave A 2 8 0 /A 5 0 0 ratios
of 2.5-4.0. This strongly suggests that there is a fraction of the
purified mutant which is unable to bind 11-cis retinal, presumably
because it is misfolded or it folds more slowly than wild-type. When
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Figure 4-3 UV / vis absorption spectra in the dark of ADRP mutants
(Class III) that show variable but low chromophore formation with 11-
cis-retinal. Twelve examples are shown. Class III mutants showed
variable 280/500 nm spectral ratios, ranging between 2.5 and 8.1. The
spectra shown were from mutants eluted from ID4-Sepharose at pH 7.0
in the presence of 150 mM NaCl.
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these mutants are purified at pH 6.0 the spectral ratio is between 1.6-
1.8. At this pH, the non-regenerable protein is selectively retained on
the 1D4-Sepharose resin. Such a spectral ratio indicates that it is
possible to obtain spectrally pure (purified wild-type rhodopsin has a
spectral ratio of 1.6) mutant chromophores. For the bleaching studies
and transducin activation assays only the pigment eluted at pH 6.0
was used.
From immunoblots these mutants all had a mature form with an
associated glycosylation smear (see class I mutants example in Figure
4-4). Such glycosylation is correlated with opsin that is transported to
the cell surface.
The mutants P23H and P23L both yielded much less
chromophore than the others at the N-terminus. The amount of
chromophore was about the same for both of these mutants, A 5 0 0 =
.006 OD (Figure 4-3). The spectral ratio of these mutants was between
6-7, suggesting that even a larger fraction of the eluted protein was
unable to regenerate i.e. more of it was misfolded. These mutants
showed three discrete bands on Western blots (Figure 4-4). These
phenotypic characteristics are the same as those observed with some
of the glycosylation mutants (e.g. N15Q) and deletion mutants (e.g.
A18-21) found at the N-terminus (Doi et al., 1990). The mutants
which show this multi-band pattern have little opsin expressed at the
cell surface as quantitated by FACS. In fact, most of the protein is
found in the endoplasmic reticulum as seen by immunofluorescence
microscopy (e.g. P23H) (Figure 4-5).
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Figure 4-4 Characterization of the three types of ADRP mutants by gel
electrophoresis. Examples of Class I - Class III mutants are given.
Equivalent amounts of purified proteins, as determined by the absorption
at 280 nm, were analyzed by SDS-PAGE (12% separating gel) and then
immunoblotted with the monoclonal antibody ID4. Lane 1 represents
wild type COS rhodopsin, Lanes 2 and 3 contain D190G and V345M,
respectively (class I mutants). Lanes 4 and 5 show the Class II mutants,
P171L and Y178C, respectively, while lanes 6 and 7 show Class III
mutants, P23L and G106W, respectively.
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Figure 4-5 Cellular localization of ADRP mutants opsins as shown byimmunofluorescence and FACS (Table 4-3). Panel A Wild type COS-1
cell opsin; Panel B the mutant P347S (Class I); Panel C the mutant
D190Y (Class II); Panel D the mutant P23H (Class III). The thin arrow
represents the cell surface for all four panels. The thick arrows in panels
C and D represent perinuclear staining consistent with localization in the
endoplasmic reticulum. Table 4-3 shows the percentage of live cells that
expressed the opsin at the cell surface.
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Table 4-4 Cell Surface Expression of Opsins from ADRP Mutant Genes
as Measured by FACS
Sample
mock
% Positive
1.48
wild-type (BFA) 0.91
wild-type 22
P23H 10
E181K 11
Q344stop
P347S
26
20
116
4.3.2 Mutants Found in the Intradiscal Loops:
G106R,G106W,C110Y,P171L,Y178C,E181K,S186P,
G188R,D19OG,D190N,D190Y
These ADRP mutants are found in either the BC loop, G106R,
G106W, C1IlOY, and in the large DE loop. So far no mutations have
been found in the FG loop. The three BC loop mutants formed
chromophore but to a lesser extent than wild-type and with poor
spectral ratios (Figure 4-3). Both of the mutants at glylO6 represent
drastically different substitutions. In one case, tryptophan represents
a bulky hydrophobic residue while arginine is a relatively large basic
amino acid. Both substitutions disrupt the gly-pro sequence in that,
loop- a sequence motif that is found in turns (Rose et al., 1985). The
mutation C10Y is significant since it disrupts the formation of the
disulfide bond between cysl10 and cys187. Prior to this study it was
believed the disulfide bond was required for the correct folding and
assembly of rhodopsin (Karnik et al., 1988; Karnik and Khorana, 1990).
This is the first example of a single mutation at cys10 that can
regenerate albeit poorly, A 2 8 0 /A 50 0 = 10-12 with A 5 0 0 = .002. Cl lOY
is light-sensitive.
The ADRP mutants of the DE loop occur primarily in the
conserved region among visual receptors, amino acids 171-189
(Hargrave and McDowell, 1992). The mutant proteins in this region,
P171L, Y178C, E181K, S186P and G188R, did not regenerate to any
significant extent (Figure 4-6). The total amount of purified opsin was
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approximately one-third of wild-type opsin. All showed a muti-band
pattern without a glycosylation smear on immunoblots ( see class II
mutants in Figure 4-4). This was similar to P23H. Such mutants have
less protein expressed at the cell surface as observed by
immunofluorescence (Figure 4-5). All of these findings are consistent
with the observations of Doi et al., (1990) who showed that deletion
mutants of in this same region had the same phenotype. Two
additional non-ADRP mutants, P170L and A170-171 (deletion of
prolines at 170 and 171) were made to see if movement of the leucine
substitution might have a different effect if it was moved by one
residue and also how removal of both proline residues would effect
the protein. P170L was expressed at wild-type levels and regenerated
like it as well (Figure 4-6). The double mutants did not regenerate at-
all (Appendix 6).
The two mutants D190G and D190N, located in the non-
conserved region, showed wild-type levels of expression and
chromophore formation (Appendix 6). These two mutants also had a
glycosylation smear as well. The mutant D190Y, on the other hand,
did not regenerate at all, like the mutants in the conserved region of
the DE loop (Appendix 6). It may be the introduction of a large amino
acid such as tyrosine effects the packing of the intradiscal loops.
4.3.3 Mutants Found in the Transmembrane Region
Helix A: F45L,G5R,G51V,P53R,TS8R
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The mutants G51R and P53R represent charge substitutions
within the helix while F45L and G51V are substitutions replacing one
hydrophobic residue with another. It is difficult to know the exact
location of thr58 in the absence of a crystal structure. From the
hydropathy profile of opsin it may lie near the cytoplasmic border
rather than within the membrane itself (Dratz and Hargrave, 1983).
All of the mutants in this helix regenerated (Figure 4-7 and Appendix
6). F45L and T58R regenerated like ,wild-type whereas the others
formed chromophore but at levels much less (<1/3) than wild-type.
F45L and T58R showed a glycosylation smear similar to wild-type
opsin while the other RP mutants of helix A showed the characteristic
muti-band pattern of those mutants which either regenerate poorly or
do not regenerate at all.
Helix B: A68-71,V87D,G89D,G90D
The mutant A68-71 is found at the top of helix B. These amino
acids are probably part of the AB cytoplasmic loop. Again, in the
absence of a three dimensional structure, we are uncertain about the
precise location of these residues. This mutant is expressed at low
levels and forms very little chromophore (Figure 4-3).
The other mutants in helix B are charge substitutions in the
transmembrane region itself. G90D is not strictly an ADRP mutant. It
was discovered in a Michigan family with congenital nyctalopia
(nightblindness) (Sieving et al., 1992). It might be expected that
burying an additional lone charge would be thermodynamically
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prohibitive and therefore such mutants would not fold properly
(Singer, 1990). All these mutants regenerated although poorly (Figure
4-2). The mutants V87D and G89D yielded less chromophore than
G90D. The Xmax of G90D was blue-shifted to 480 nm. This particular
residue may either form part of the retinal binding pocket or interact
indirectly with 11-cis retinal. These mutants also showed a multi-
band pattern by immunoblots.
Helix C: L25R,R135L
L125R represents a charge substitution within the helix whereas
R135L is a neutral substitution at the top of the helix. It neutralizes
one member of a conserved charge pair found in many mammalian'
pigments (Sakmar et al., 1989). Both of these mutants were
expressed at wild-type levels- and yielded chromophore similar to
wild-type (Figure 4-2). These mutants also showed a glycosylation
smear (Figure 4-3).
Other Transmembrane Mutants:
C167R, H211P,1256A,K296E
C167R is a charge substitution in helix D while H211P removes a
potential charge from within the membrane domain of helix E. These
mutants do not regenerate at all (Figure 4-6). I256A is a single amino
acid deletion at the top helix E. It , along with the mutant A255-256
(deletion of isoleucine residues at those positions), regenerated at very
low levels (Appendix 6). K296E represents a substitution at the lysine
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residue forms a Schiff base with 11-cis retinal This mutant would not
be expected to regenerate. This mutant as well as K296D and K296R
do not regenerate at all although the amount of opsin purified is about
three fourths of wild-type. On immunoblots K296E has a glycosylation
smear like class I mutants. There is no multi-band pattern unlike
other mutants that did not regenerate.
4.3.4 Mutations at the C-Terminus:
Q344stop,V345M, P347L, P347S
Like the N-terminus the C-terminal tail of rhodopsin is believed
to be exposed to the aqueous phase. The mutant V345M was the only
one which could be successfully purified on the 1D4-Sepharose 4B'
antibody column. It regenerated like wild-type rhodopsin and had a
similar glycosylation smear (Appendix 6 and Figure 4-4). The mutant
Q344stop did not bind to the resin at all. It did form chromophore like
wild-type as demonstarted by taking light/dark difference spectra of
the dodecyl maltoside solubilized cell extract (Appendix 6). The
mutants P347L and P347P when eluted from the immunoaffinity
column showed small amounts of chromophore with high spectral
ratios (Appendix 6). This is because the epitope of 1D4 requires the
P347 for efficient binding to rhodopsin. On immunoblots probed with
4D2, an N-terminal antibody all these mutant proteins had
glycosylation smears like wild-type.
ADRP patients are heterozygous for the mutant allele i.e. they
have one copy of the mutant gene and one copy of the wild-type gene.
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To mimic the in vivo genotype COS-1 cells were co-transfected with
both the wild-type and Q344stop plasmids. Since Q344stop does not
bind to antibody column we would be able to study the in vivo effect
of this mutant gene on wild-type expression. As seen in Figure 4-3,
the level of expression and the amount of chromophore is not
drastically effected in the presence of Q344stop but the spectral ratio
is greater than for wild-type alone. This suggests that the presence of
the mutant allele may effect the amount of wild-type opsin that is
properly assembled and transported. Of course this model tissue
culture expression system may not be completely analogous to what
occurs in the rod cell's inner segment.
4.3.5 Expression of Wild-Type Opsin in the Presence of-
Brefeldin A (BFA)
One concern in regenerating whole cells is whether 1-cis
retinal is able to penetrate into other membrane compartments
besides the plasma membrane. Because of its hydrophobic nature 11-
cis retinal most likely partitions into the first membrane it encounters
In this way the opsin which is in the ER and Golgi membranes may
encounter it at significantly lower concentrations. This may, in part,
explain the poor spectral ratio of many of the ADRP mutants like P23H
which are retained in the ER.
Brefeldin A is a macrocyclic lactone made from palmitate. It
was initially found to have antiviral activity but was later on
discovered to block protein secretion at some early step.
124
Subsequently it has been found to block protein transport from the ER
to the Golgi by disrupting the Golgi membrane structure (Klausner e t
al., 1992). Membrane or secreted proteins that are expressed in the
the presence of BFA are retained in the ER maintain only the high
mannose carbohydrate moieties. When expressed in the presence of
BFA (3 gg/ml) wild-type opsin was not expressed at the cell surface as
determined by FACS (Table 4-4) . From immunoblots this protein ran
as a single band with a molecular weight slightly larger than ROS
rhodopsin (Mr= 40,000) (Figure 4-8). No glycosylation smear was
present. Nearly all of this speices was sensitive to endoglycosidase H,
an enzyme that recognizes high mannose structures. Furthermore
when this protein was regenerated and purified it gave wild-type
expression and chromophore levels suggesting that in fact 1 1-cis-
retinal is able to penetrate internal membrane compartments (Figure
4-8).
4.3.6 Bleaching Properties of the ADRP Mutants that
Regenerated
The bleaching behavior of the RP mutants that regenerated was
studied. When wild-type rhodopsin is illuminated and then acidified a
distinct 440 nm species is formed (Appendix 2). As mentioned
previously, this species represents the covalent Schiff base linkage
between all-trans retinal and lys296 without any contributions from
chromophore-opsin interactions. This covalent linkage is preserved
upto the ml intermediate ( m a x = 380 nm) whereafter it is
hydrolyzed, releasing all-trans retinal (max= 380 nm) from the
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Figure 4-8 Expression of opsin in the presence of Brefeldin A (5#g/ml).
A) UV / visible absorption spectra of wt(BFA). B) Endoglycosidase H
sensitivity of ROS rhodopsin, COS rhodopsin and wt(BFA).
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Figure 4-9 Absorption spectral shifts as observed on bleaching of
different ADRP mutants. Purified ADRP mutants were illuminated for
various lengths of time at 20°C and the solutions were then acidified by
the addition of 2N H2SO4 to a final pH of 1.9. In all cases, the
absorption spectra in the dark are labeled "1" and each subsequent
number represents a 10 sec illumination with a fibre optic light source
with a 495 nm cut off filter. In the case of Gly90-Asp no cut off filter
was used. The spectrum with the largest number in each panel
represents the chromophore on acidification.
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once the pigment did isomerize free all-trans retinal was quickly
released.
The mutant G90D bleached more quickly at room temperature-
upon acidification there was no species absorbing between 420-440
nm, the entire 380 nm species represented free all-trans retinal. But
when the bleaching was done at 4C the blue shifted chromophore of
480 nm first formed an intermediate of 460 nm, probably the mI-like
species for this mutant, which then slowly formed a 380 nm species
upon further illumination.
4.3.7 Transducin Activation
Some of the mutants were also characterized by their ability to
trigger transducin inthe GTPyS exchange assay. As expected from the
bleaching studies the mutants which showed faster release of all-trans
retinal (e.g. T4K and T17M) were less efficient in allowing nucleotide
exchange of transducin (Figure 4-10). These results suggest much
greater quantities of mutant pigment are required to acheive the same
level of transducin activation as wild-type rhodopsin. Also shown in
Figure 4-10 are the activation curves for F45L and L125R. Both of
these mutants have bleaching characteristics like wild-type but
nevertheless are less efficient in triggering transducin except at very
high concentrations. This difference proabably reflects the difference
int the binding constant of the mII-like species in these mutants for
transducin. The mutant K296E as purified from the 1D4 antibody
column does not activate transducin.
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4.3.8 Purification of Mutants on K16-50-Sepharose4B
Resin
As discussed above many of the ADRP mutants have poor
spectral ratios indicating that some fraction of the eluted protein does
not bind 11-cis retinal. Most likely this fraction is misfolded.
K16-50 is a C-terminal monoclonal antibody like 1D4. However
its epitope is located further up, amino acids 335-342 (Adamus et al.,
1991)). An antibody column with this antibody was made just as
previously described and wild-type rhodopsin and some ADRP
mutants were purified with it. As shown in Figure 4-11, the eluted
protein, in the case of wild-type, from this immunoaffinity column-
does not contain any chromophore. The supernatant from the binding
was applied to the 1D4 resin. All of the regenerated opsin was found
in the eluate of that resin (Figure 4-11). The mutant K296E and P347S
were also purified on the K16-50 column. When the eluates of these
mutants and wild-type opsin were run on SDS-polyacrylamide gels
and immunoblotted with 4D2, three distinct bands were observed like
that seen P23H and P171L (mutants that regenerated at low levels or
not at all). No glycosylation smear was noticed. Taken together this
implies the K16-50 antibody column recognizes the unfolded form of
opsin. Secondly, this experiment suggests that even for wild-type
opsin there is a fraction which is either in an unfolded or denatured
state. Finally it appears the fraction eluted from this column has three
separate non-regenerable species.
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4.3.9 Extraction of COS-1 Cell Membranes
One method to assess if a protein has been inserted completely
into a membrane is to try extracting it with 0.1 M sodium carbonate
pH 11.3 (Bonifacino et al., 1991)). At high pH peripheral and partially
inserted proteins are extracted whereas integral membrane proteins
stay bound to the membrane.
COS cell membranes were prepared. The supernatant from the
membrane pellet was kept to see if any soluble forms of opsin were
present. Equal volumes of purified opsin from the 0.1 Na2 CO 3 extract,
the solubilized membrane pellet remaining from the extraction
procedure and the supernatant from the membrane pellet were run on-
SDS-polyacrylamide gels and then immunoblotted with 4D2. As seen
in Figure 4-12, for wild-type P23H, P171L and V345M two fractions
were extracted from the membranes. The slower moving form, so-
called mature form had a Mr= 40,000, similar to ROS rhodopsin. The
faster migrating form had a Mr= 35,000 which co-migrated with
unglycosylated opsin. For wild-type and V345M there is some opsin
which has an associated glycosylation smear. The relative fraction of
opsin that was extracted with sodium carbonate was 10% for wild-
type, 25% for P23H (class III), 30% for P171L (class II) and 15% for
V345M (class I). The greatest fraction of sodium carbonate
extractable opsin was from the mutants which had the poorest
regeneration characteristics. In all four samples the largest fraction of
opsin was still in the membrane. There was also a significant amount
of opsin in the supernatant of the membrane preparation. This
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Figure 4-12 Extraction of opsin with 0.1 M sodium carbonate.
Wt(COS), P23H (Class III), P171L (Class II), and V345M
(Class I). M= membrane pellet remaining after carbonate
extraction; Na2 CO3= opsin extracted with Na2 CO3; S=
supernatant of membrane preparation prior to extraction with
Na2 CO3.
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represents a soluble fraction of opsin. For both P23H and P171L
besides the two molecular weight species discussed above there is an
intermediate band, Mr= 37,000, that was also present. It could be a
form which has only glycosylation at one of the N-linked glycosylation
sites.
4.3.10 Phase Separation of Opsin with TritonX-114
TritonX-114 (TX114) has a cloud point at 30°C where the
detergent forms large, dense micelles that precipitate out of solution
thereby creating an aqueous and detergent-rich phase. Because of this
unusual property it has been exploited for determining if a given
protein is an integral membrane protein or a soluble one (Bordier,-
1981). For example, when bacteriorhodopsin is solubilized with TX114
and the sample incubated at 30°C greater than 98% of this integral
membrane protein partitions into the detergent phase. For
hemoglobin, greater than 98% partitions into the aqueous phase.
The phase behavior of wild-type, P23H, P171L and V345M was
studied using TX114. Figure 4-13 shows that for COS-1 cell wild-type
and the mutants there is an equal distribution of the opsin in the
detergent and aqueous phases. For wild-type and V345M there is an
large aqueous phase fraction which has a glycosylation smear. This is
somewhat different from what was observed by sodium carbonate
extraction. TX114 does appear to solubilize only the mature opsin
fraction- none of the lower molecular weight species are present. The
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Figure 4-13 Phase partitioning of wild-type opsin and ADRP mutants
with 1% Triton X-114. COS opsin, P23H (Class II), P171L (Class II),
and V345M (Class I). D = detergent - rich phase. A = aqueous phase.
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difference may reflect the mechanism by which these two methods
interact with opsin.
4.4 DISCUSSION
Retinitis Pigmentosa (RP) is an eye disease in which the
photoreceptor cells are destroyed leading to retinal degeneration and
eventual blindness. The clinical hallmarks of this disease include
nyctolopia (nightblindness), mid-peripheral vision loss and diminished
ERG's. It is the most common form of blindness among middle-aged
persons, occurring in 1/3000 people (Heckenlively, 1988).
Over the past few years the groups of Driyja, Bhattacharya,--
Nathans, Stone and Seiving have identified a large number of
mutations in the rhodopsin gene associated with autosomal dominant
retinitis pigmentosa (ADRP). These mutations are believed to account
for approximately 30% of all ADRP patients (S. Bhattacharya, personal
communication). These mutations are distributed throughout the
protein. The types of amino acid substitutions are variable. For
example, some are replacements of neutral residue with a charged one
(e.g. P23H, G89D), others are the introduction of bulky residue (e.g.
C1lOY, D190Y) while others are the removal of a charge (e.g. R135L).
In a few instances there are deletion mutations such as A68-71 and
I256A. How do all these different types of mutations lead to the
disease? Do they have a common pathogenetic mechanism or are
there mutiple mechanisms?
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To begin understanding this problem our laboratory has used
site-directed mutagenesis to construct, express and purify these
mutants. Initially, we studied how well the mutants were able to fold
by their ability to bind 11-cis retinal. We quantitated our operational
definition of the extent of folding by the presence and amount of
chromophore formed. The mutants fell into three categories (Table 4-
3). The majority of the mutants were expressed at low levels and
formed chromophore but at low levels. For example P23H a large
fraction of the purified protein did not regenerate. Furthermore it was
abnormally glycosylated and retained in the ER. Together these
findings indicate the mutant did not fold efficiently or certain non-
native, off-pathway, structures were favored. Indeed, it is known that
proteins which fold slowly or are misfolded are retained in the ER
where they may eventually be targeted for degradation (Bonifacinoet
al., 1990; Klausner and Sitia, 1990; Wikstrom and Lodish, 1992; Shin et
al., 1993). A mutant like P23H may have a high rate of degradation
explaining in part the low levels of expression. In fact on
immunoblots of this mutant (and others like it as well) there often are
protein bands which have a smaller molecular weight than
unglycosylated opsin. These are probably degradation products. The
abnormality in glycosylation most likely then reflects the protein's
inability to leave the ER rather than a true defect in the inability of
the mutant to acquire the mature glycosylation smear.
P23H is an N-terminal mutation but there are many mutations
within the transmembrane region (e.g. P53R, V87D) and the intradiscal
loops (e.g. G106R) which also had a similar phenotype. One mutant
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was a deletion on the cytoplasmic face, A68-71. The expression level,
amount of chromophore and spectral ratio of the mutants in this class
varied. In general, the spectral ratio reflects the extent of
regeneration i.e. the higher the A 2 8 0 /A 5 0 0 ratio the greater the
unregenerated fraction. Q28H had a low spectral ratio of 3.0 while
P23H had a high ratio, 6.5. Although there was some variability from
transfection-to-transfection these results are reproducible. Increasing
the time of regeneration did not increase the amount of chromophore.
Such variation would imply the rate of folding in COS-1 cells is
different for the members of this mutant class.
Since these mutants were retained in the ER one reason why
they could not completely regenerate was their inaccessibility to 11--
cis retinal. However when wild-type rhodopsin was artificially
retained in the ER by expressing it in the presence of Brefeldin A this
protein fully regenerated indicating that 11-cis retinal can penetrate
the internal membrane compartments of COS-1 cells.
Many of the mutations in this class occur within the
transmembrane region, clustered in helix A and B. It was surprising
some of the charge substitution mutants within this domain like G51R
and G89D regenerated because of the unfavorable energetics of
burying charges in a hydrophobic environment. We do not know the
interaction of the native amino acids which are sites of the ADRP
mutations. It could be these two helices are less important in the
overall assembly of the retinal binding pocket or the charge
substitutions are stabilized by other intra-protein interactions. Or the
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mutation effects the efficiency of folding or possibly how the protein is
inserted into the membrane, during or after synthesis.
If the transmembrane segments are -helices the amino acids
gly89 and gly90 would be rotated by 100 degrees from one another.
The RP mutations at these sites, G89D and G90D, are identical charge
subtitutions. Both regenerated but G90D was expressed at higher
levels and formed greater amounts of chromophore. Furthermore it
had a blue-shifted chromophore with a max of 480 nm. Although
glul 13 is believed to be the primary counterion for the Schiff base in
native rhodopsin the aspartic acid in the RP mutant clearly alters its
spectral properties. It probably directly interacts with 11-cis retinal
in the dark state. This mutant also bleaches more quickly on-'
illumination suggesting it also plays a role in the conformational
changes accompanying photoisomerization.
One particularly interesting mutant in this class is C10Y.
CyslO10 and cysl87 are believed to form the single disulfide bond in
rhodopsin which is critical for its assembly. There are eight other
cysteine residues found throughout the protein including the
transmembrane region (e.g. cys167, cys222) and cytoplasmic surface
(e.g. cysl40, cys316). The ADRP mutant at cysl10 is the first single
amino acid substitution at this site which regenerated although at
extemely low levels ( A 5 0 0 = .002). The extent and amount of
regeneration was similar to that observed for Cys X, a mutant which
retained only cysl10 and cys187 (Karnik et al.,1989). Upon
illumination C1 lOY did form a 380 nm species. This would imply the
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disulfide bond is not strictly required for the folding and assembly of
rhodopsin but may affect the rate of folding and/or the stability of
folded opsin.
The class III mutants had bleached rapidly and were less
efficient in triggering transducin.
The second group of mutants (class II) were those which did not
form any chromophore at all. They were primarily clustered in the
conserved region of the DE loop on the intradiscal surface (e.g. Y178C,
S186P). However some were found in the transmembrane domain
including helix D (e.g. C167R, P171L), E (e.g. H211P) and F (e.g. I256A).
No mutant proteins from helix A, B or C fell into this class. They were
expressed at low levels, had abnormal glycosylation and were also
retained in the ER. Thse mutants probably reflect mutations which
either grossly alterred the structure of the retinal binding pocket
thereby outrightly preventing the binding of 11-cis retinal or
configured the retinal binding pocket in such a way the Schiff base
linkage was not stable i.e. the rate of hydrolysis of the Schiff base was
greater than its rate of formation. We tried to regenerate these
mutants with all-trans retinal but no chromophore was observed.
Doi et al. (1990) described a similar phenotype for a set of
deletion mutants in the conserved region of the DE loop. In general,
one may expect such deletions to affect the folding and assembly of
opsin more dramatically than a substitution since it changes the actual
length of a structural element. Our laboratory has found that small
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two amino acid deletion mutants of opsin in the BC loop do not fold (A.
Anukanth and H.G.K. manuscript in preparation). Of course if an amino
acid is critical for establishing or maintaining certain tertiary contacts
within the protein than a substitution at that site could have drastic
effects on folding. This is observed in the ADRP mutants in the
conserved portion of the DE loop. In this case we are uncertain about
its exact structure or how much of it is in the membrane since the
aqueous-lipid boundaries are unknown. It is quite a large region
extending from amino acids 171-189. Furthermore because it is
conserved in the mammalian visual receptors one may surmise it is
important for structure i.e. help establish the retinal binding pocket.
Cys187 is found in this region and mutations in its vicinity may
prevent the formation of the disulfide bond.
The boundary region of helix D has two vicinal prolines at
positions 170 and 171. Prolines are known to introduce kinks into ca-
helices (MacArthur and Thornton, 1991; von Heijne, 1991; Yun et al.,
1991). It is probably unlikely these residues actually are part of an a-
helix but may be part of a critical structural component of the retinal
binding pocket. The ADRP mutant P171L does not form chromophore.
As such it may destroy the retinal binding pocket. On the other hand
P170L, a non-RP mutant, regenerated to wild-type levels. This result
suggests this residue does not directly participate in the folding or
assembly of rhodopsin. However it may be one of many residues in
the membrane that faces away from the retinal pocket and interact
with the surrounding lipids.
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The mutant K296E is a special member of this class. It did not
form any chromophore because the lys residue required for forming
the Schiff base linkage was absent. This mutant when purified in 0.1%
LM from the 1D4 column did not activate transducin. Oprian's group
reported this mutant was contitutively active when it was present in
the membrane bound form (Robinson et al., 1992). Either this mutant
is extremely sensitive to detergents or there is a separate fraction
which has the ability to trigger transducin but is not recognized by
1D4. We found the K16-50 antibody column recognized a fraction of
wild-type COS-1 cell opsin that did not regenerate. This species had a
muti-band pattern by immunoblots without a glycosylation smear. A
similar fraction was found for K296E.
The class I mutants regenerated like wild-type, had
glycosylation smear and were -transported to the cell surface. They
also had bleaching properties similar to wild-type except for T58R.
These mutations were found in helix A (e.g. F45L), helix C ( e.g. L125R)
and at the C-terminus (e.g. V345M). These mutants in the
transmembrane region were also less efficient in triggering transducin.
Those amino acids subtitutions must effect the the conformation of the
binding surface of mII that interacts with transducin.
We studied the membrane insertion of one member of each
group. In the four cases studued we found ther was a fraction of opsin
that was extractable including wild-type. But we found for P23H and
P171L a greater fraction of the opsin could be extracted with sodium
carbonate suggesting a larger fraction of the mutant protein was not
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embedded entirely in the membrane. Whether this represented a
significant difference is uncertain. But if is is true for other members
of each class it would partially explain the folding defects in those
mutant classes. We also found there was a soluble fraction in all cases
as well.
Using a heterologous expression system (293S human embryonic
kidney cells), Sung et al. (1991) reported on the ability of some ADRP
mutants to bind 11-cis retinal and their cellular localization. This
group, however, did not purify the mutant opsins. Furthermore, prior
to taking light/dark difference spectra hydroxylamine was added (50
mM final concentration) without actually knowing the dark reactivity
of the mutant to this potent nucleophile. As mentioned in the-
previous chapter some rhodopsin mutants are reactive to
hydroxylamine.
Driyja's group (Olsson et al., 1992) reported on the
characterization of transgenic mice carrying the mutant allele P23H.
They demonstrated these mice developed retinal degeneration and
showed dilatation of rod inner segments in at least one clone, P23H-L,
suggesting that some fraction of the mutant protein may be retained
in the ER. Interestingly, they also reported that wild-type human
opsin, when expressed at high levels in a transgenic mouse could also
lead to a phenotype very similar to that observed with P23H.
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Other investigators have also shown that misfolded or
abnormally glycosylated proteins are retained in the endoplasmic
reticulum and stably associated with at least one resident ER
chaperone, Bip (Machamer et al., 1990; Suzuki et al., 1991). Bip
(heavy chain binding protein) is a member of the hsp70 family of heat
shock proteins whose expression is induced when the cells are exposed
to such stressful events as elevated temperature, exposure to certain
drugs (e.g. tunicamycin, cyclohexamide) and by the ER retention of
misfolded mutant proteins. Other ER chaperones are also induced as
well, such as grp94 (the ER equivalent of hsp90) and the folding
enzyme protein disulfide isomerase (PDI), cyclophilin B, an protein
with peptidyl prolyl isomerase activity, and calreticulin (Gething and
Sambrook, 1992).
In drosophila, a mutation in the nina A gene results in the ER
retention of one particular type of rhodopsin, presumably because it is
misfolded (Colley et al., 1991). This sequestration is believed to
subsequently cause rod cell degeneration. This group believes the
nina A gene encodes a peptidyl prolyl isomerase specific for rhodopsin
(by sequence homology). Furthermore, they have found that in the
presence of the nina A background certain mutations in rhodopsin
result in a wild-type phenotype, without retinal degeneration (Charles
Zuker, personal communication). This is one example of how the
interaction of a foldase with rhodopsin may lead to retinal
degeneration.
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We did not find any convincing evidence to establish the
association of these chaperones with the ADRP mutants retained in the
ER
In the case of the cystic fibrosis transmembrane regulator (CFTR)
the most common mutation associated with the disease, F508A
(deletion of phenylalanine at position 508), is a temperature-sensitive
folding mutant (Denning et al., 1992). When expressed at 37°C in CHO
or COS cells, the non-permissive temperature, little functionally active
protein is found at the cell surface. Indeed most of the mutant CFTR
protein is found in the ER. At 27°C, the permissive temperature, much
more of the properly folded protein is found at the cell surface and is
functionally active. This study does not speculate why at 370 C, the-
mutant is retained in the ER. Some of the ADRP class III mutants were
expressed at lower temperature in COS-1 cells but no increase in cell
surface expression was detected.
The present investigation represents the largest study of all
ADRP mutants. Obviously, from this study there is tremendous
heterogeneity among the mutant ADRP proteins. How they all lead to
retinal degeneration is not clear. From our results a vast majority of
the ADRP mutants fold inefficiently or are simply misfolded. Both
classes of mutants are retained in the ER and are not transported to
the cell surface. This may be what is occurring in the rod inner
segments of these patients. However, it is unclear how the presence of
one normal opsin gene modulates the expression of the mutant.
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What is more puzzling is how mutants that appear like wild-type
except for their inefficient triggering of transducin cause RP. Such
mutants may have defects in other aspects of structure and function.
Much more must be done before a clear picture of the molecular
pathogenesis of ADRP emerges.
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APPENDIX 1
SPECTRA OF GLYCOSYLATION MUTANTS
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BLEACHING SPECTRA OF THE GLYCOSYLATION MUTANTS
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APPENDIX 4
GTPS EXCHANGE ASSAY OF OTHER GLYCOSYLATION
MUTANTS
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APPENDIX 5
EXPRESSION OF N2Q, N15Q AND N2,15Q IN THE PRESENCE OF
TUNICAMYCIN
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APPENDIX 6
UV /VIS ABSORPTION SPECTRA OF ADRP MUTANTS
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APPENDIX 7
BLEACHING SPECTRA OF ADRP MUTANTS
199
4dl; 1 ',* t .LA i - - . a,-: a: '
1 i r
ii 1 S ;F'
_, j~ ] I
A. .3_
13, -j I4 E
- I
i
?
4 i
- . -Y---
486. 458. 
mlm
?: i1818!0;
, i 2Sa -
absc ·1nt :.VI ;rd -, ;- .
9/ 1/1
P 3L
.31!98 -
1 dark
r" h1.
3 T ai IV
4 acid
e3 146
. 8894 - !
i I 
-, ;
d. 8842 '-
-__. R-o ; _0 --~.AfitH
258.8 38.8 358.8 488.8 458.0 500,0 550.8 88ae.
NM
200
658,
- - , 1 i R-4 ;a c 3 c 55 8 a Z S. , 1 ~, -
I ,A? 1 3 qn'i 1-,, 
i'7 9lI
2SOA6 300.0 350.0 580 . 550.0 3 -80A 
558.0 28A; pts
~~~~~~~~a i 1 R ' c r.'4 a- S e@ >'E|-'>5'5+i; i A A R -U d4-'
It-~~~~~~~~ r - 3 3 6j .v ; ?1
46 - / ·
· f28 q
F~~~~~FS
1~~~~~~~~~~~~~~~4,, 2:, L,
:-' ....- -- ~ . i.. -
. a42 - -' r- ;.;..- -.. --
~, .-. ·Lr.i,,,, . s;;., .. =L .-'-~-W :. ~--j ~~~~~~~~~~~~ ~~~~~ ~~~~~~~--. '
{z"S'--. ...":":'...._.
~~~~~~~~~~~~~~~~~~~~~~~"'"' .ba .'mi-_ zR 1R-..- 
Zt5B. 0 388.8 358. 488 0 450. 0 500,8 558.8 6a0,8 58a.8
]nt' 18' !4'28 92/!!1
.- F45L 2 10" k.
836 . ifrf~~~~~~~~~~~~~~~~~~~~~~ ci~.t
~.46 ? 1 lr
0,0278 -' ! .2 , 1
i
l~~ ~ ~~~~~~~ - .t8.88 ;; I 
.
,.
d.881 0 -,
i~ ~ ~~~~~~. . '.....-.._ c .'. "
-.~~~~~~~~~~~~~~~~~
9. i4Q^ ----- ~-C - --- _
25~1.a 39.8 350. 0 488.3 459.a 5B8.8 55. >8.i
201
2,3 4 !
25s 9 380. 9 358, 488. 458, 0 50. 55a.a 68l,9 65aS
m
.llw_
! J 4- . ;t .- n 
;i ; , , 
- - L i,
: r r-C~ivi
,' .
5t l, ,ti
! " -vi~~~~~~ ~~  J ., ;] r R t a
' i0, l!
2 - I 1V
i a~lct
"cip'I li 
A R '49 -
.ta -- IJ=;, (_-.'I.C /
A
,,128 '
A430
'i ' 4 , i .. .I a ,
in: 18'80;1 
8 0I 88 - .~:
, i
a a320 - I
- ?1i 
9. 248 - i I !1 ,
I wf I
A A j - -
.... I -8. tU10U
A AID
s - 9c- i,
2/1/ .12 t'11/0!
JiJ 4 . UV; .In A. -sf 5;. a
,. I , . U I LI .U .UUU U . IxJ
1 i ark
: !0:'i)
2 E i1 1i v
f Uir li
- C ilA438
t
r
---  2
i I
-3·· 
'
i
.4
LLfpL.,-.--_-
:.
259.9 300.B 358.8 490.0 458.0 588.0 350.0 6~.B
Nm
202
- A 4 I c_ ; -- - - . 4 A % + '
_ _ J .. I b - I
-. S a
AI ~ ~ ~ ~ ~ 3 434
0040
258,0 388.8 358,8 488. 458.8 588.8 558 8 688.8 5@ 8 
.i .3- . .
~~~~~~~~~~~~~~."iL"~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~_ _ _
3 01e
1: 181845; absec
;;.f' 16:49:'8 9:
-a.328 -
658.8- 258.8; pts 4t
T 5R
, i.S
-J, 8Z56 -/
8.8192 | 44
0.8864 --
Y .{ .,L -
81; int 1i88; rd -888- 80298:
2 1C" Iv
3 t +1' " 
4 +28" hv
5 acid.
258.8 388.8 358.8 488.8 458.8 588.9 558.0 689.8 65.8
203
-u I I " -
i
k
::ni~i -1ac 2_!- '.4 4 i .; 9
U i -/U -
'I cak
3 ACL It
i; ~  ~ ~ ~ ~~~~~~~~ -4-'-
I; Bk ~ I · r
'7952 9 q,9. 35909 49A 0 4? , R0
NMi
44 + -, .i _ i4 -4 4 ; a !, I v .. ,, , -. . i.- ,C 4 .
. Uinf' U3: J'! :; '8 ./! 0 .U '
I nf '^ ?- ? I -' I- 
1U7 D
1 , . '
) 4aci d_
3 a- ' 1
·OL - e
F
.I
I 
';
fI:I
'A
.
,~ i.-,t
/58 0 30. 0 35.8 498.9 45.
204
i
I
-! i
'.
: 
j | --
_i - U __ ·_ ._ C _ 
.1 - ; .3 !, 'i - .3 J A '. - 'I ti A -, 
9i
_.1 -2 _ 
I
-41 
rRA.o 550'a 600A9 650.6
so6. 0 q(;A R A P. 
.dsc ni -i!o, iz 5 -4
~ i -G89D
i ?-. 2 30' hv
ii
,1 1
-'..- \ .'" ....
3 ._-- -- -8 38 . 8-
'" ;; -. ' ...-.- , .-'
if.
-'0. , - ,~1
,,,.t ·· -- rr "-. r---
,
i '-_-.~6-_......-:'
,:..i~: .......
A i;~~~~~'""-' 
-
-:-:::'.-]:'-T'- ...
.... ->=. ,_,.-..1.:= .._
25) it.~ 3 B 0~ 50 ~ 5t.! 5, ~ S,
205
, zU _au J , ~.Uv ',r ~i .' t ~in .jU .l sl t, _u J, , .*. AU1Lsts 5ni iV. i" ? oC · I.J- Ji V .V J j
:,-,' 8 iq ?4 l g?,i:'
'Z91 ~~ ~ ,~ `3Hi ii . 4.\' R~~,030 078 X t < i E ^+ 4 ; ',' k1
G90~ b' Pn teach!~¥~ ,: _ I :v;.I '.l" %-
;, 6 acid
, .- . _ , .- .. _ 
... .. r
, .A_- ~. .
0.B~~~~~~~~tB~~~ -'_ ~, - :--.; '.
: :
. ~ '-, - '-:-.---:i.;-:-. "--
R~ ^,0r, . .'
R RAIQ '
39. 0 350. 480.8 45. 
4,
58.9 550.8 608.8 0508
'>-o7~ 'sn
itf, !4'1 :38 9:
I: 
,~ r
iu |
4'n ~~~~~\
I C , a- ? 1: FA R ' , t d i ; ,,t i 8 , aQ | ju...VV . ..V.V r . . , , .
?f 11 /1
Z,/!f~/S 0
gl8br
-u, ,,, a . . ' , ? 70
U ." I. U l ; ..... W , i, . .
I~i
2 lo" v
3 .,ci,
3 1
m .,--uc----
= -iJ' -=
s-·-
r
259.8 3809.8 358.8 480. 8 458.9
mm
500.0 558.9 600A
206
i J - - -
3 arc
a ~a?')
A
;, ) ONIJ. nu40 2. J
258.8 308.0 358.0 488.0 459,9
...
,_ ; I2 2 
i 48i -
.
., J.I '
. i 
.3 -, 1 t.
!
Q9:.' 8/3
K- i
'I k- J 1 ,-1I .
.) ic i
3
S0.9 550.0 59.80 '9R .
207
i
__.LI___· ··
__
i J- I --r
'Cz
r,-
.,,
i --- 
---------- -i--;-__ . _ _---__,_
L -'- V1i
,~ -) ' i . a
R. 9R -
I
ii
li
ili
k-ri .
·-CI-.C
,- I
·-n-,
K` pl
-yh-i
·( 
· L=LIIl·C- .X, ·,
-*u-
Zi,, C,
500.0 558.0 680.0 650.8
2550 39. 358.0 400.9 4S.Rl
...I.1..; SC 6 . . .-~ 2 t1 -41.Q 
*:;- !3'53 41 92/11,81
d t78 -7.l8 ,
' t,
{ 23 i
8,8 042 -
8. a2 -
. .-..
- I!3 a,, .- I .,~ -
R. 48 .- -- ' .k25 .-0 3.4 45 .6 58 . 55 4.8 60, ,
Ul n L 1i iV
3 acid
3 1
8,8248 ' 
A,8 .6
8,8888 i
25. 30.8 0 358. 0 408. 45.8 58. 5508,8 60088. 658.8
208
_ _
-c'
---
Re ferences
Adamus, G., Zam, Z.S., Arendt, A., Palczewski, K., McDowell, J.H., and
Hargrave, P.A. (1991) Vision Res. 31,
Andersson, S., Davis, D.N., Dahlback, H., Jornvall, H., and Russell, D.W.
(1989) J. Biol. Chem. 264, 8222-8229.
Baldwin, J.M. (1993) EMBO J. 12, 1693-1703.
Berson, E.L., Rosner, M., Sandberg, M.A., and Driyja, T.P. (1991) Arch.
Ophthalmol 109, 92-101.
Bhattacharya, S., Ridge, K.R., Knox, B.E., and Khorana, H.G. (1992) J. Biol.
Chem. 267, 6763-6769.
Bhattacharya, S.S., Inglehearn, C.F., Reen, J., Lester, D., Bashir, R., and
Bird, A.C. (1991) Invest. Ophthalmol. Vis. Sci. (suppl.) 32, 890.
Blatz, P.E., Mohler, J.H., and Navangul, H.V. (1972) Biochemistry 11,
848-855.
Boege, F., ard, M., Jurss, R., Hekman, M., and Helmreich, E.J.M. (1988) J.
Biol. Chem. 263, 9040-9049.
Bonifacino, J.S., Suzuki, C.K., and Klausner, R.D. (1990) Science 247, 79-
82.
Bonifacino, J.C., Cosson, P., Shah, N., and Klausner, R.D. (1991) Embo J.
10, 2783-2793.
Bordier, C. (1981) J. Biol. Chem. 256, 1604-1607.
Cohen, G.B., Oprian, D.D., and Robinson, P.R. (1992) Biochemistry 31,
12592-12601.
209
17-31.
Colley, N.J., Baker, E.K., Stamnes, M.A., and Zuker, C.S. (1991) Cell 67,
25 5-263.
Cooper, A. (1979) Nature 282, 531-533.
Davidson, D.J., Bretthauer, R.K., and Castellino, F.J. (1991) Biochemistry
30, 9811-9815.
Denning, G.M., Anderson, M.P., Amara, J.F., Marshall, J., Smith, A.E., and
Welsh, M.J. (1992) Nature 358, 761-764.
Dixon, R.A.F., Sigal, I.S., and Strader, C.D. (1988) Cold Spring Harb.
Symp. LIII, 487-497.
Doi, T., Molday, R.S., and Khorana, H.G. (1990) Proc. Natl. Acad. Sci. USA
87, 4991-4995.
Dratz, E.A. and Hargrave, P.A. (1983) Trends Biochem. Sci. 8,
Dryja, T.P. (1992) Eye 6,
128-131.
1-10.
Dryja, T.P., McGee, T.L., Reichel, E., Hahn, L.B., Cowley, G.S., Yandell,
D.W., Sandberg, M.A., and Berson, E.L. (1990) Nature 343, 364-
366.
Dryja, T.P., McGee, T.L., Hahn, L.B., Cowley, G.S., Olsson, J.E., Reichel, E.,
Sandberg, M.A., and Berson, E.L. (1990) New Engl. Journ. Med.
323, 1302-1307.
Dryja, T.P., Hahn, L.B., Cowley, G.S., McGee, T.L., and Berson, E.L. (1991)
Proc. Natl. Acad. Sci. USA 88, 9370-9374.
Elbein, A.D. (1987) Ann. Rev. Biochem. 56, 497-534.
Ferretti, L., Karnik, S.S., Khorana, H.G., Nassal, M., Oprian, D.D. (1986)
Proc. Natl. Acad. Sci. USA 83, 599-603.
210
Findlay, J.B.C., Brett, M., and Pappin, D.J.C. (1981) Nature 293, 314-
316.
Fliesler, S.J. and Basinger, S.F. (1985) Proc. Natl. Acad. Sci. USA 82,
1116-1120
Franke, R.R., Konig, B., Sakmar, T.P., Khorana, H.G., and Hofmann, K.P.
(1990) Science 250, 123-125.
Franke, R.R., Sakmar, T.P., Graham, R.M., and Khorana, H.G. (1992) J.
Biol. Chem. 267, 14767-14774.
Fung, B.K.K., Hurley, J.B., and Stryer, L. (1981) Proc. Natl. Acad. Sci. USA
78, 152-156.
Fukuda, M.N., Papermaster, D.S., and Hargrave, P.A. (1979) J. Biol.
Chem. 254, 8201-8207.
George, S.T., Arbabian, M.A., Ruoho, A.E., Kiely, J. and Malbon, C.C.
(1989) Biochem. Biophy. Res. Comm. 163, 1265-1269.
George, S.T., Ruoho, A.E., and Malbon, C.C. (1986) J. Biol. Chem. 261,
16559-16564.
Germann, U.A., Willingham, M.C., Pastan, I., and Gottesman, M. (1990)
Biochemistry 29, 2295-2303.
Gething, M.J. and Sambrook, J. (1992) Nature306, 33-45.
Gonnet, G.H., Cohen, M.A., and Benner, S.A. (1992)Science 256, 1443-
1448.
Hargrave, P.A. and McDowell, J.H. (1992) Internatl. Rev. Cytol. 137B,
49-97.
Heckenlively, J.R. (1988) In "Retinitis Pigmentosa" Lippencott,
Philadelphia, PA.
211
Hubbard, S.C. and Ivatt, R.J. (1981) Ann. Rev. Biochem. 50, 555-583.
Hong, K. and Hubbell, W.L. (1972) Proc. Natl. Acad. Sci. USA 69, 2617-
2621.
Iismaa, T.P. and Shine, J. (1992) Curr. Opinion Cell Biol. 4, 195-202.
Janssen, J.J.M., van de Ven, W.J.M., van Groninggen-Luyben, W.A.H.,
Roosien, J., Vlak, J.M., and de Grip, W.J. (1989) Molecular Bio. Rep.
13, 65-71
Karnik, S.S. and Khorana, H.G. (1990) J. Biol. Chem. 265, 17520-17524.
Karnik, S.S., Ridge, K.R., Bhattacharya, S., and Khorana, H.G. (1993) Proc.
Natl. Acad. Sci. USA 90, 40-44.
Karnik, S.S., Sakmar, T.P., Chen, H.-B., and Khorana, H.G. (1988) Proc.
Natl. Acad. Sci. USA 85, 8459-8463.
Khorana, H.G. (1992) J. Biol. Chem. 267, 1-4.
Khorana, H.G., Knox, B.E., Nasi, E., Swanson, R., and Thompson, D.A.
(1988) Proc. Natl. Acad. Sci. USA 85, 7917-7921.
Kito, Y., Suzuki, T., Azuma, M., and Sekoguti, Y. (1968) Science 218,
955-957.
Konig, B., Arendt, A., McDowell, J.H., Kahlert, M., Hargrave, P.A., and
Hofmann, K.P. (1989) Proc. Natl. Acad. Sci. USA 86, 14767-
14774.
Klausner, R.D. and Sitia, R. (1990) Cell 62, 611-614.
Kornfeld, R. and Kornfeld, S. (1985) Ann. Rev. Biochem. 54, 631-664.
Knudsen, P. and Hubbell, W.L. (1978) Mem. Biochem. 1, 297-322.
212
Kuhn, H., Hall, S.W., and Wilden, U. (1982) Biochemistry 21, 3014-
3022.
Laemmli, U.K. (1970) Nature 277,
Laird, D.W., Wong, S.Y.C., and Molday, R.S. (1987) In "Membrane
Proteins, Proceedings of the Membrane Protein Symposium (S.C.
Goheen, ed.) Bio-Rad Laboratories, Richmond, CA 45-70.
Lippincott-Schwartz, J., Yuan, L.C., Bonifacino, J.S., and Klausner, R.D.
(1988) Cell 54, 209-220.
Luckow, V.A. and Summers, M.D. (1988) Biotechnology 6, 47-55.
MacArthur, M.W. and Thornton, J.M. (1991) J. Mol. Biol. 218, 397-412.
Machamer, C.E., Doms, R.W., Bole, D.G., Helenius, A., and Rose, J.K.
(1990) J. Biol. Chem. 265, 6879-6883.
Matsumoto, H., Tokunaga, F., and Yoshizawa, T. (1975) Biochim.
Biophys. Acta 404, 300-310.
Nakayama, T.A. and Khorana, H.G. (1990) J. Biol. Chem. 265, 15762-
15769.
Nakayama, T.A. and Khorana, H.G. (1991) J. Biol. Chem. 266, 4269-
4275.
Nathans, J. (1990) Biochemistry 29, 937-942.
Nathans, J., Weitz, C.J., Agarwal, N., Nir, I., Papermaster, D.S. (1989)
Vision Res. 29, 907-914.
Olsson, J.E., Gordon, J.W., Pawlyk, B.S., Roof, D., Hayes, A., Molday, R.S.,
Mukai, S., Cowley, G.S., Berson, E.L., and Dryja, T.P. (1992) Neuron
9, 815-830.
213
680-685.
Oprian, D.D., Molday, R.S., Kaufman, R.J., and Khorana, H.G. (1987) Proc.
Natl. Acad. Sci. USA 84, 8874-8878.
Owen, J.J., Kissonerghis, A.M., and Lodish, H.F. (1980) J. Biol. Chem.
255, 9678-9684.
Ovchinnikov, Y.A., Abdulaev, N.G., and Bogachuk, A.S. (1988) FEBS Lett.
230, 1-5.
Ridge, K.R., Bhattacharya, S., Nakayama, T.A., and Khorana, H.G. (1992)
J. Biol. Chem. 267, 6770-6775.
Robinson, P.R., Cohen, G.B., Zhukovsky, E.A., and Oprian, D.D. (1992)
Neuron 9, 719-725.
Rothman, J.E. and Lodish, H.F. (1977) Nature 269, 775-780.
Sakmar. T.P., Franke, R.R., and Khorana, H.G. (1989) Proc. Natl. Acad.
Sci. USA 86, 8309-8313.
Sanger, F., Nicklen, S., and Coulson, A.R. (1977) Proc. Natl. Acad. Sci.
USA 74, 5463-5467.
Schertler, G.F.X., Villa, C., and Henderson, R. (1993) Nature362, 770-
772.
Schichi, H. (1983) In "Biochemistry of Vision" Academic Press, New
York, NY.
Schichi, H., Adams, A.J., and Kobata, A. (1980) Neurochemistry
253.
Shin, J., Lee, S., and Stominger, J.L. (1993) Science 159, 1901-1904.
Sieving, P.A., Richards, J.E., Bingham, E.L., and Naarendrop, F. (1992)
Invest. Ophthal. Vis. Sci. (abstract suppl.), 1397.
214
1, 245-
Sheffield, V.C., Fishman, G.A., Beck, J.S., Kimura, A.E., and Stone, E.M.
(1991) Am. J. Hum. Genet. 49, 699-706.
Singer, S.J. (1990) Ann. Rev. Cell Biol. 6, 247-296.
St. Jules, R.S., Wallingford, J.C., Smith, S.B., and O'Brien, P.J. (1989) Exp.
Eye Res. 48, 653-665.
Summers, M.D. and Smith, G.E. (1987) In " A Manual of Mehtods for
Baculovirus Vectors and Insect Cell Culture Procedures" Texas
Agricultural Experiment Station Bulletin No. 15555 College
Station, TX.
Sung, C.H., Davenport, C.M., Hennessey, J.C., Maumenee, I.H., Jacobson,
S.G., Heckenlively, J.R., Nowakowski, R., Fishman, G., Gouras, P.,
and Nathans, J. (1991a) Proc. Natl. Acad. Sci. USA 88, 6481-6485.
Sung, C.-H., Schneider, B.G., Agarwal, N., and Papermaster, D.S. (1991b)
Proc. Natl. Acad. Sci. USA 88, 8840-8844.
Thiem, S.M. and Miller, L.K. (1990) Gene 91, 87-94.
von Heijne, G. (1991) J. Mol. Biol. 218, 499-503.
Wang, J.K., McDowell, K.H., and Hargrave, P.A. (1980) Biochemistry 19,
5111-5117.
Weiss, E.R., Heller-Harrison, R.A., Diez, E., Crasnier, M., Malbon, C.C., and
Johnson, G.L. (1990) Journal of Molec. Endocrin. 4, 71-79.
Wessling-Resnick, M. and Johnson, G.L. (1987a) J. Biol. Chem. 262,
3697-3705.
Wessling-Resnick, M. and Johnson, G.L. (1987b) J. Biol. Chem. 262,
12444-12447
Wilden, U. and Kuhn, H. (1982) Biochemistry 21, 3014-3022.
215
Wikstrom, L. and Lodish, H.F. (1992) J. Biol. Chem. 267, 5-8.
Yun, R.H., Anderson, A., and Hermans, J. (1991) Proteins: Struc. Func.
Gen. 10, 219-228.
Zhukovsky, E.A. and Oprian, D.D. (1989) Science 246, 928-930.
Zhukovsky, E.A., Robinson, P.R., and Oprian, D.D. (1991) Science 251,
55 8-560.
Zhukovsky, E.A., Robinson, P.R., and Oprian, D.D. (1991) Biochemistry
31, 10400-10405.
Zozulya, S.A., Gurevich, V.V., Zvyaga, T.A., Shirokova, E.P., Dumler, I.L.,
Garnovskaya, M.N., Natochin, M. Y., Shmukler, B.E., and Badalov,
P.R. (1990) Prot. Engineering 3, 453-458.
216
